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ABSTRACT 
Microfluidics has shown great potential in rapid isolation, sorting, and 
concentration of bioparticles upon its discovery. Over the past decades, significant 
improvements have been made in device fabrication techniques and microfluidic 
methodologies. As a result, considerable microfluidic-based isolation and concentration 
techniques have been developed, particularly for rapid pathogen detection. Among all 
microfluidic techniques, dielectrophoresis (DEP) is one of the most effective and efficient 
techniques to quickly isolate and separate polarizable particles under inhomogeneous 
electric field. To date, extensive studies have demonstrated that DEP devices are able to 
precisely manipulate cells ranging from over 10 µm (mammalian cells) down to about 1 
µm (small bacteria). However, very limited DEP studies on manipulating submicron 
bioparticles, such as viruses, have been reported. 
In this dissertation, rapid capture and concentration of two different and 
representative types of virus particles (Sindbis virus and bacteriophage M13) with 
gradient insulator-based DEP (g-iDEP) has been demonstrated. Sindbis virus has a near-
spherical shape with a diameter ~68 nm, while bacteriophage M13 has a filamentous 
shape with a length ~900 nm and a diameter ~6 nm. Under specific g-iDEP experimental 
conditions, the concentration of Sindbis virus can be increased two to six times within 
only a few seconds, using easily accessible voltages as low as 70 V. A similar 
phenomenon is also observed with bacteriophage M13. Meanwhile, their different DEP 
behavior predicts the potential of separating viruses with carefully designed 
microchannels and choices of experimental condition. 
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DEP-based microfluidics also shows great potential in manipulating blood 
samples, specifically rapid separations of blood cells and proteins. To investigate the 
ability of g-iDEP device in blood sample manipulation, some proofs of principle work 
was accomplished including separating two cardiac disease-related proteins (myoglobin 
and heart-type fatty acid binding protein) and red blood cells (RBCs). Consistent 
separation was observed, showing retention of RBCs and passage of the two spiked 
protein biomarkers. The numerical concentration of RBCs was reduced (~70 percent after 
one minute) with the purified proteins available for detection or further processing. This 
study explores and extends the use of the device from differentiating similar particles to 
acting as a sample pretreatment step. 		 	
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CHAPTER 1 
INTRODUCTION 
 
1.1 Microfluidic Techniques 
Microfluidics is the science and technology of systems that process or manipulate 
small amounts of fluids (10-9 to 10-12 liters), and sorts particles in microchannels with 
characteristic “length” scale L on the order of tens to hundreds of micrometers, where L 
represents a hydraulic diameter or channel height or width [1]. The fluid phenomena that 
dominate liquids at this length scale are measurably different from those that dominate at 
the macroscale [2]. For instance, the relative effect of the gravity at microscale 
dimensions is greatly reduced while it is dominant at the macroscale. Conversely, with 
the dramatic increase of the surface-to-volume ratio when reducing the channel 
dimension to microscale, surface tension and capillary forces are more dominant in the 
system.  
These forces can be used for a variety of applications such as passively pumping 
fluids in microchannels [3], filtering various analytes [4], and forming monodisperse 
droplets [5, 6]. The very first application of microfluidic techniques is in chemical 
analysis [7, 8]. Since then, a variety of advantages for microfluidics have been well 
demonstrated, including low cost, use of small quantities of samples and reagents, rapid 
analysis, high resolution and sensitivity, compactness, and controlled multifunctionality 
[9]. These particular advantages have attracted considerable attention from molecular 
biology, since microfluidics is thought to be well suited for some molecular biology 
related research (e.g. high-throughput DNA sequencing) and improving analytical 
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methods with high resolution and sensitivity [10]. Meanwhile, the successful 
development of photolithography and associated technologies in microelectronics and 
microelectromechanical systems (MEMS) offered unique tools for fabrication of 
microfluidic devices, which significantly facilitated and expanded the applications of 
microfluidics [2]. The basic principles of photolithography and some other associated 
techniques are discussed in Chapter 2. In MEMS, silicon and glass are used as the 
primary materials for microfluidic device fabrication. However, as the technologies have 
advanced, especially in soft lithography, silicon and glass have been largely replaced by 
polymers for fabricating microfluidic devices used for analysis of biological samples. In 
1998, Whitesides and co-workers used soft lithography method with 
polydimethylsiloxane (PDMS) as the material to fabricate complex microfluidic devices 
[11]. Since then, this technique has become the most widely used technique for 
fabricating microfluidic devices. Over the past two decades, numerous microfluidic 
devices with different purposes and functions have been fabricated. These devices are 
commonly referred to as miniaturized/micro total analysis systems (µTAS) [7, 12] or lab-
on-a-chip (LOC) technologies. These devices can be further applied to a variety of 
applications, including separation and concentration of particles [13], high-throughput 
screening in drug development [14, 15], bioanalysis [16], single cell analysis [17], and 
diagnostics [18-20]. Among all the applications, biological or biomedical applications 
constitute the majority, indicating the great ability of microfluidics in solving biological 
problems.  
 
1.2 Manipulation of Bioparticles with Microfluidics 
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Bioparticles, including cells, bacteria, viruses, aggregates, organelles, exosomes, 
proteins, RNA, and DNA, play crucial roles in biological systems and are the machinery 
for various biological phenomena and diseases. They cover a very wide range of sizes, 
from as small as 1-10 nm (proteins) to as large as 50-100 µm (cells) (Fig. 1-1).  These 
bioparticles have their own characteristic physical features and biological functions 
(Table 1-1). For example, red blood cells (RBCs) have a shape of an oval biconcave disk 
and deliver oxygen to body tissues through the circulatory system. 
 
Figure 1-1. Size comparison of various bioparticles. 
 
Manipulation of the bioparticles is of great importance in various biomedical and 
biotechnological applications [26-29]. There have been a tremendous number of methods 
developed for bioparticle manipulation for both fundamental research and clinical studies 
[30, 31]. In all these methods, separation and concentration play important roles as the 
pretreatment of biofluid sample before further analysis and diagnosis. Traditional 
macroscale techniques in this field includes centrifugation [32], filtration [33], 
fluorescence or magnetic activated separation [34-37], and electric field-based techniques 
[38-40]. Among them, the electric field-based approaches can be relatively easily-
	 4 
modified for miniaturization and integration with microfluidics. This is due to the 
convenience of generating and structuring an electric field in microscale, e.g. on 
microchips [41]. Over the past decades, this concept has been well demonstrated and 
several electric field-based microfluidic devices have been designed, fabricated, and 
applied, indicated by a booming publication record [2, 42, 43]. 
Table 1-1. Features and functions of bioparticles 
 
Bioparticles 
Features 
Functions 
Structure Shape 
Nucleic acid  
(DNA, RNA) 
[21] 
Macromolecules composed of 
nucleotides, which are composed 
of a 5-carbon sugar, a phosphate 
group and a nitrogenous base. 
Depending on the type of the 
sugar, this biomolecule can be 
categorized to either DNA (with 
ribose) or RNA (with 
deoxyribose). 
Both DNA and RNA 
can be a double 
stranded or single 
stranded helix. 
Create, encode, store 
and express information 
Protein [21, 22] 
Macromolecules consisting of one 
or more long chains of amino acid 
residues 
Differences in the 
amino acids sequence 
will result in a specific 
three-dimensional 
structure through 
protein folding. 
Catalyze metabolic 
reaction, DNA 
replication, stimuli 
response, transport 
molecules 
Virus [21] 
Genome (DNA or RNA) is 
enclosed by a protein coat 
(capsid). Some of them may have 
an extra shell (envelope), which is 
made of lipids, surrounding the 
capsid. 
Viruses come as 
various shapes, though 
a majority falls in an 
icosahedral structure 
and rod/filamentous 
shape.[23] 
Infectious agent 
replicates only inside the 
living cells of other 
organisms. 
Red blood cell 
[24] 
The cell membrane is composed 
of lipids and proteins with no cell 
nucleus and most organelles. 
Mature red blood cells 
are flexible, oval 
biconcave disks. 
Vehicle for delivering 
O2 to body tissues and 
transporting CO2 to the 
lungs through the 
circulatory system 
White blood cell 
[25] 
The cell membrane is composed 
of lipids and proteins with cell 
nucleus and organelles enclosed. 
Detailed structure varies with the 
specific type.  
Irregular in shape Immune system cells to 
protect the body against 
infectious disease and 
foreign invaders 
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These well-developed electric field-based microfluidic devices show good 
performance of handling bioparticles. Only tiny sample volume is required for analysis, 
maintaining one major advantage of microfluidic technology. Furthermore, they also 
show advantages of rapid operation, low cost, flexibility, portability, controllability, and 
ease of application to automation [41, 44]. 
In general, electric field-based microfluidics refers to the manipulation of 
electrically charged or uncharged particles in a microfluidic device in the presence of an 
applied electric field. The applied electric field introduces electroosmosis (EO) in the 
microchannels, as well as electrophoresis (EP) and dielectrophoresis (DEP) on the 
particles. Electrophoresis creates the motion of charged particles in an electric field 
(uniform or nonuniform), whereas DEP creates the motion of polarizable particles 
(charged or uncharged) only in a nonuniform electric field. More details on the theory are 
presented in Chapter 2. Electroosmosis, EP and DEP can all be utilized for separation and 
concentration of bioparticles. For example, EP has been used in combination with EO for 
separation of molecules and cells in microfluidic devices [45-47]. Furthermore, 
depending on the nature of bioparticles to be concentrated or separated, different types of 
electric field (e.g. DC or AC) or microchannel designs can be applied in order to 
manipulate the EP or DEP forces introduced on the bioparticles. DEP properties of 
bioparticles not only depend on their charge state, but also their structure, morphology, 
shape and size. Due to this, a wider range of bioparticles can be concentrated or separated 
by applying DEP in theory [48]. To date, DEP-based microfluidics has been successfully 
applied to concentrate and separate a variety of bioparticles including blood cells [49-53], 
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cancer cells [54-58], stem cells [59], bacteria [40, 60-63], viruses [64-67], nucleic acids 
[68, 69], proteins [70-72], and others.  
The work in this thesis focuses on developing and applying a DEP-based 
microfluidic device for concentration and separation of bioparticles including viruses, 
blood cells, and proteins.  
 
1.3 Dissertation Overview 
This dissertation focuses on the development and application of gradient 
insulator-based dielectrophoresis (g-iDEP) microfluidic devices in manipulating various 
bioparticles. Given the previous successful experience with relatively larger bioparticles, 
such as red blood cells and bacteria [50, 61, 62], the work presented in this dissertation 
primarily focuses on smaller particles, especially in submicron range, such as viruses. 
The potential application of this g-iDEP device as a pretreatment tool for biological 
sample is also explored and discussed.  
Realizing that microfluidic techniques rely greatly on the convenient fabrication 
techniques, a general introduction on microfluidic device fabrication is detailed in 
Chapter 2. Additionally, main electrokinetic mechanisms are comprehensively explained 
because they are the foundation of manipulating particles in the introduced g-iDEP 
microchannel. At the end of the chapter, two generations of the microchannel designs are 
described. The most recent microchannel design is able to increase the resolving ability 
and extending the range of capture to smaller analytes, especially submicron bioparticles.   
Chapter 3 presents the successful application of the optimized g-iDEP device in 
manipulating Sindbis virus. The investigation demonstrates consistent capture and 
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concentration of Sindbis virus under a DC electric field with easily accessible low 
potential. Chapter 4 reconfirms the manipulation of submicron bioparticles using this new 
g-iDEP device with bacteriophage M13. Comparing with Sindbis virus, similar capture 
and accumulation phenomena were observed with bacteriophage M13. However, these 
two types of viruses behave different under chosen experimental condition, indicating the 
potential of separating different viruses by carefully tuning the experimental condition.  
Given the fact that bioparticles in all sizes, from relatively larger RBCs and 
bacteria to smaller viruses, are all successfully manipulated in the g-iDEP device, it is 
presumed that this g-iDEP device can be utilized for clinical application, such as sample 
pretreatment. In Chapter 5, preliminary investigation has been performed by purifying a 
biomarker protein (myoglobin or heart-type fatty acid binding protein) sample from its 
mixture with RBCs. In the end, Chapter 6 summarizes the work presented in this 
dissertation and discusses the future prospects. 
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CHAPTER 2 
BACKGROUND AND THEORY 
 
2.1 Microfluidic Device Fabrication 
The applications of microfluidics have expanded over the past decade. There has 
been increased interest in micro- and nanofabrication for developing advanced 
microfluidic systems, from materials to fabrication techniques. In this section, a brief 
discussion of common materials and techniques for fabrication is presented, followed by 
the general fabrication routine used in this dissertation. 
2.1.1 Materials 
The common substrates for microfluidic devices are silicon, glass and a variety of 
polymers. In the early development of microfluidics, the devices were made from silicon 
and glass with the techniques adapted directly from semiconductor and 
microelectromechanical systems (MEMS) manufacturing. Silicon has been well studied 
from structure to property to application and it has been widely used in semiconductor 
industry. It has a high thermal conductivity and the ability to fabricate thin membranes, 
which reduce thermal mass and enable high temperature ramp rates [1, 2]. However, 
silicon is expensive and optically opaque to certain electromagnetic wavelengths, limiting 
its application in some fields such as optical detection. Glass is chemically stable and 
transparent, which is particularly attractive when optical detection methods such as 
fluorescence or surface plasmon resonance (SPR) are used. However, similar to silicon, 
the high-quality glass materials such as fused silica and quartz that have no impurities 
and excellent optical properties are significantly more expensive. More than that, another 
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challenge with fabricating glass-based microfluidic devices is the requirement of high 
temperatures or large electric fields to bond device layers together. In the late 1990s, with 
the concept of using polymer materials in microfluidics being proposed [3], the use of 
silicon and glass materials has shifted to polymer materials, primarily due to their low 
cost, disposability and ability to adapt to several biomaterials and diagnostic applications 
[4]. These polymer materials include polydimethylsiloxane (PDMS), 
polymethylmethacrylate (PMMA), polystyrene (PS), and polycarbonate (PC). Among all 
these materials, PDMS is the most commonly used material for fabrication of 
microfluidic devices in recent years due to its optical transparency, flexibility in molding 
and stamping, and biocompatibility. Most recently, paper has been used as a substrate of 
microfluidic devices because of its ability to transfer aqueous solutions [5, 6]. The pore 
size in paper can be well controlled in manufacturing process so that the paper can be 
used as a size exclusion chromatography device. In addition, paper is inexpensive, 
disposable, and biocompatible with various biological samples. There are other 
techniques developing quickly, which will impact the field in the future.  
2.1.2 Fabrication Techniques for Microfluidic Devices 
The general fabrication process for microfluidic devices involves several steps 
e.g. photolithography, etching, and bonding. For polymer-based microfluidic devices 
fabrication, soft lithography techniques are utilized, including micromolding, 
microcontact printing and other techniques. All device fabrication begins with substrate 
cleaning and definition of channels or other features on a blank substrate by methods of 
photolithography. 
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Photolithography is a common process used in microfabrication to pattern parts of 
a thin film or the bulk of a substrate. It predominantly uses ultraviolet light to transfer a 
geometry pattern from a photomask to a light-sensitive chemical photoresist, e.g., 
AZ4620, on the substrate. For higher-resolution patterns, expensive technologies such as 
electron beams, X-ray, or ion beams are used in the photolithography. Generally, a series 
of steps are included, such as photomask creation, wafer cleaning, photoresist 
application, UV exposure, and development. Fig. 2-1 shows a simplified and general 
illustration of photolithography. 
 
Figure 2-1. An illustration of photolithography with (a) positive photoresist and (b) 
negative photoresist. 
 
The creation of the photomask begins from a square glass or quartz plate covered 
with a full layer of chromium. A laser beam or electron beam is used to create the pattern 
designed by computer software on the chromium surface. The chromium can be etched 
away under laser beam. As a result, a photomask with a transparent path is created. The 
transparent path allows UV light to penetrate through since the glass or quartz is 
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transparent to UV light while chromium blocks the light. The fabricated photomask can 
be further utilized to define the geometric pattern over the wafer in the step of UV 
exposure. After wafer cleaning, photoresist application is followed to cover the wafer 
with a thin-film photoresist by spin coating. Photoresist is a light-sensitive polymer. With 
a given mask, either positive or negative photoresist can be selected, depending on what 
regions would be protected during UV exposure. Usually, positive photoresist can 
provide better resolution while negative photoresist is more durable. After UV exposure, 
photoresist at specific regions could be removed by a special solution, called "developer". 
With positive photoresist, exposed regions are soluble in the developer. However, with 
negative photoresist, unexposed regions are soluble in the developer. After photoresist 
application, the wafer is exposed under UV light with the photomask on it to create the 
designed geometric pattern on the wafer. The photomask is placed in direct contact or 
proximity contact (10–20 mm) above the photoresist-coated wafer. After UV exposure, 
the photoresist is then developed to remove the undesired regions.  
 
Figure 2-2. An illustration of fabricating geometric features by (a) deposition and (b) 
etching. 
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Photolithography can be followed by deposition or etching to form the actual 
features on the substrate (Fig. 2-2). For deposition, materials such as silicon dioxide, 
polysilicon, silicon nitride, and metal are deposited onto the substrate with a common 
approach, termed “physical vapor deposition (PVD)”. Followed by a lift-off process, 
undesired regions can be removed. For etching, a liquid ("wet") or plasma ("dry") 
chemical agent removes the uppermost layer of the substrate in the areas that are not 
protected by photoresist. The common etching solutions or gases include hydrofluoric 
acid (HF), nitric acid (HNO3), acetic acid (CH3COOH), and sulfur hexafluoride (SF6). 
For polymer-based microfluidic devices fabrication, soft lithography is used as a 
primary method. Soft lithography represents a non-photolithographic strategy based on 
self-assembly and replica molding for carrying out micro- and nanofabrication [7]. It is 
typically used to generate patterns and structures with feature sizes ranging from 30 nm 
to 100 µm [7]. Compared to other forms of lithography such as photolithography and 
electron beam lithography, soft lithography has several unique advantages including low 
cost, excellent flexibility, good compatibility with multiple systems, and more pattern-
transferring methods. In soft lithography, two primary techniques have been 
demonstrated: micromolding and microcontact printing (Fig. 2-3).  
Micromolding is a thermal form-change method for creating three-dimensional 
(3D) microstructures. It enables large-scale production of polymeric devices with high 
accuracy. PDMS is used as the most common polymer in recent years. It is elastomeric 
silicon-based organic polymer with an average Young’s modulus around 750 kPa [8]. 
When fabricating devices, PDMS is poured over wafers with designed features and then 
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left to harden. After removal, all details of the structure features are left imprinted in the 
PDMS layer. The PDMS layer is flexible and is able to be removed without damage. 
Therefore, microfluidic channels and other features on the micron scale can be fabricated 
with high fidelity. In the projects present in the thesis, micromolding and PDMS were 
used to fabricate the microfluidic devices. 
 
Figure 2-3. General illustration for micromolding and microcontact printing with PDMS. 
 
Microcontact printing is a fabrication technique based on self-assembly. A 
polymer-based stamp, usually made of PDMS, is coated with an alkanethiol and then 
brought into contact with a substrate (usually silicon) that has a thin layer of gold 
deposited on the surface. A self-assembled monolayer (SAM) forms in the regions where 
the stamp comes into contact with the gold surface [9].  
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However, at the current stage of development, soft lithography still relies on the 
use of photolithography to generate the master. Once the master is available, most of the 
fabrication tasks can be continued outside a clean room with the use of only a printing or 
molding procedure. 
2.1.3 Substrate Bonding 
Most microfluidic devices require bonding of substrates to create enclosed 
volumes for fluid handling. Silicon-to-silicon bonding can be accomplished by fusion 
bonding with high-temperature annealing (300-800°C) in oxygen or nitrogen two [10]. 
Silicon-to-glass bonding can be realized by anodic bonding techniques in which 1000 V 
direct current is applied across the composite with the glass as the cathode and the silicon 
as the anode [10]. For polymer-based microfluidic devices fabrication, fusion bonding 
and anodic bonding are not applicable since polymer materials cannot handle high 
temperature and high voltage. Instead, other techniques including oxygen plasma 
bonding, thermal compression and gluing are widely used. For bonding PDMS layers, 
oxygen plasma bonding is commonly used [11]. After oxygen plasma treatment on 
PDMS surfaces for a short period time (1-2 min), the PDMS layer can attach onto glass 
substrate or another PDMS layer with strong cohesion and irreversible seal, which 
enables the fabrication of enclosed well-defined microchannels.  
In the work presented in this thesis, the microfluidic device is fabricated using a 
photomask designed in-house using PDMS. Briefly, by applying photolithography 
(positive photoresist) and etching, a silicon wafer is first made with the designed device 
pattern. PDMS was then used to mold the device pattern with the wafer. Then, oxygen 
plasma was used to treat the surface of PDMS and glass slide for contact sealing. As a 
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result, the designed channel was created between the PDMS cast and glass slide. A 
general illustration of fabricating enclosed microfluidic channel with PDMS is given 
(Fig. 2-4) [12, 13].  
 
Figure 2-4. Schematic representation of fabricaitng the microfludic device. 
 
2.2 Electroosmosis 
Electroosmosis (EO) is the one of the dominant flows for the transportation of the 
sample in a microfluidic device. This phenomena was originally discovered by Reuss 
[14] as the liquid can be made to flow through a porous dielectric material with electric 
voltage applied. For example, with external voltage applied, water can flow through the 
narrow spaces between closely packed particles of silica and other minerals.  
	 22 
From the device fabrication (Fig. 2-4), the channel will be formed between the 
PDMS and the glass slide. The oxygen plasma treatment transforms methylsilyl group 
(Si-CH3) to silanol groups (Si-OH)) on surface of the PDMS [11, 15], which is also the 
channel wall for the microfluidic device. During the process of filling the channel with 
aqueous solution, the deprotonation of the silanol groups results in a negatively charged 
surface. The negative charge on the surface attracts counter-ions (cations) from the 
solution while repelling anions.  This leads to a relatively compact and immobile cation 
layer right next to the PDMS surface, termed Stern layer (Fig. 2-5B). Moving away from 
the surface, the electrostatic force decreases and leads to a layer loosely associated to the 
Stern layer. This loosen layer is termed diffuse layer, containing mainly cations (Fig. 2-
5B).  
 
Figure 2-5. Schematic of electroosmosis (EO) and illustration of electrical double layer 
(EDL). (A) In a PDMS made microfluidic channel, the channel wall is negatively 
charged. The flow profile of EOF arises from zero at the solid-liquid interface and 
reaches steady uniform flow throughout the cross section of the channel. This velocity 
originates from the negatively charged surface of the channel under the application of 
external electric field. (B) Further details on the charge distribution of EDL, forming at 
the solid-liquid interface. Because of the negatively charged surface of the PDMS wall, 
some cations from aqueous solution are attracted by Coulomb force and form an 
immobile layer (Stern Layer) right at the interface. The diffuse layer formed adjacent to 
the Stern layer, is composed of ions (mainly cations) loosely attached and can diffuse 
freely. EDL is defined as the combination of Stern layer and diffuse layer. Its 
characteristic thickness is termed Debye length, 𝜆% . The electric potential 𝜓 decreases 
linearly from 𝜓' at the solid-liquid interface, to zeta potential 𝜁 at the shear plane, further 
decreased exponentially across the diffuse layer and reaches zero at an infinite point in 
the bulk solution to the solid-liquid interface.  
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As depicted in Fig. 2-5B, the electric potential 𝜓 at the interface, 𝜓', relies on the 
surface charge density. Across the Stern layer, 𝜓  typically drops linearly. Further 
extending to the diffuse layer and bulk solution, 𝜓 drops exponentially and reaches zero 
at an infinite point in the bulk solution to the solid-liquid interface. At the shear plane 
separating Stern layer and diffuse layer, the potential is known as the zeta potential (𝜁) 
[16]. The characteristic thickness of EDL is defined as Debye length and its expression is 
described below for a symmetrical binary electrolyte (i.e. 𝑧 -	𝑧 electrolyte) [17], 
 𝜆% = ,-,./01#234356  (2-1) 
where 𝜀8 denotes the permittivity of vacuum, 𝜀9 is the relative permittivity of the medium, 𝑘; is the Boltzmann constant, T is the temperature, 𝑒 is the elementary charge, 𝑧 is the 
electrolyte valence, and 𝑛> is the mean concentration of charge particles.  
Once an external electric field (𝑬) is applied along the longitudinal direction of a 
PDMS channel, the net charges (positive charges) in EDL will start to move under the 
Coulomb force and prompt the bulk liquid motion in channel. As shown in Fig. 2-5A, the 
corresponding profile of EO exhibits a flat profile outside the EDL region. The velocity 
of EO (𝝊AB) can be estimated using Helmholtz-Smoluchowski Equation [16, 18]: 
 𝝊AB = ,-,.CD 𝑬  (2-2) 
where 𝜂 stands for the viscosity of the medium. 
The terms which precede 𝑬  are commonly expressed as the linear coefficient 
between 𝝊AB and 𝑬. It is refered to as the EO mobility (𝜇AB), indicating the EO velocity 
under unit field strength [16, 18, 19]: 
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 𝜇AB = 𝝊GH𝑬 = ,-,.CD  (2-3) 
 
2.3 Electrophoresis 
Electrophoresis (EP) is another important contributor to the electrokinesis, which 
derives from interactions between macroscopic motion and diffuse electric charge [17]. It 
is the motion of individual charged particles relative to the suspension aqueous medium 
under the application of an external electric field [14, 18]. For example, regarding a 
suspension of negatively charged particles with an applied electric field, the particles will 
move towards the positively charged cathode while the surrounding counter-ions will be 
attracted by anode, and vice versa. A simplified illustration of electrophoresis was given 
for different charged particles in electric field (Fig. 2-6).  
 
Figure 2-6. Schematic illustration of electrophoresis (EP). The charged particle moves 
under the application of electric field. Positive charged particle moves along the electric 
field direction, and vice versa, as depicted by the arrow directions. The length of the 
arrows is representative of the corresponding strength of the EP force, which is 
proportional to the charge of the particle. 
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For a spherical particle with radius 𝑟 and charge 𝑞 within a uniform electric field 𝑬, the EP force (𝑭AL) acting on it can be expressed as: 
 𝑭AL = 𝑞𝑬  (2-4) 
Based on the Stokes’ law, if the particle is suspended in a solution with viscosity 𝜂, the drag force (also known as the frictional force, 𝑭M),  
 𝑭M = 6𝜋𝜂𝑟𝒗 (2-5) 
where 𝒗 is the fluid velocity relative to the particle. 
A terminal velocity will be achieved when the total force on the particle equals 
zero, which is: 
 𝑭AL + 𝑭M = 0 (2-6) 
Therefore, the electrophoretic velocity 𝒗AL of the particle would be same in magnitude 
but in an opposite direction of 𝒗: 
 𝒗AL = −𝒗 = − T𝑬UVD9 (2-7) 
From this equation, it is clear to see that 𝒗AL is proportional to the applied electric field 𝑬, which defines the electrophoretic mobility 𝜇AL as [20]: 
 𝜇AL = 𝒗GW𝑬 = − TUVD9 ≈ − #,-,.CYZD  (2-8) 
where 𝜁[ is the zeta potential, i.e., the electrokinetic potential of the slipping plane in the 
EDL around the particle. 
The above situation happens with a “thick double layer” around the particle, in 
which case the field lines are almost unaffected by the particle. In the “thin double layer” 
case, the expression of electrophoretic mobility was give by Smoluchowski [18, 19], 
which is:  
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 𝜇AL = − ,-,.CYD  (2-9)  
The electrophoretic mobility is characteristic for particles with different charge to 
radius ratio and enables the corresponding separation between them, e.g. capillary 
electrophoresis. 
Considering a charged particle suspending in an electrolyte within narrow 
channels with surface charge, such as a PDMS microfluidic channel, the overall 
electrokinetic velocity 𝒗A\  is the superposition of both EO and EP, which can be 
expressed as: 
 𝒗A\ = 𝒗AB + 𝒗AL = (𝜇AB + 𝜇AL)	𝑬 (2-10) 
Therefore, the corresponding electrokinetic mobility 𝜇A\ can be defined as: 
 𝜇A\ = 𝜇AB + 𝜇AL (2-11) 
 
2.4 Dielectrophoresis 
Dielectrophoresis (DEP) is the motion of the polarized particle suspending in the 
medium relative to that of the medium in an inhomogeneous electric field.[21] Different 
from electrophoresis introduced above, it doesn’t require the subject particle to have a net 
charge.  It originates from the relative dielectric properties of the particle and the solvent. 
For more or less ‘perfect bodies’, a low conducting material can be polarized when it is 
exposed to an electric field. The electric charges distribute to form a dipole or multiple 
dipoles within the material because the electric charges slightly shift or reorient according 
to the applied electric field. This can be referred to as polarization of the material. 
Starting with a vacuum, divergent electric field acts upon the induced dipole, as well as 
permanent dipoles, forcing them move towards regions of highest electric field strength. 
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When the material is dispersed in a liquid medium, DEP is governed by both the 
polarization of the particle and that of the medium. When the particle exhibits a higher 
polarizability than the surrounding medium, the non-uniform electric field will drive the 
particle to a higher electric field strength, where the particles can be concentrated [21].  
2.4.1 Spheres 
The derivation of the simplest form of the dielectrophoretic force (or DEP force, 𝑭%AL ) on a particle is based on several assumptions: a lossless, homogeneous and 
isotropic dielectric sphere with a radius 𝑟 and absolute permittivity 𝜀[, suspending in a 
fluid dielectric medium of permittivity 𝜀_ = 𝜀8𝜀9 [22]. 
 𝑭%AL = 2𝜋𝜀_𝑟Z𝐶𝑀∇𝑬# (2-12) 
In the above expression, CM is representative of the Clausius-Mossotti factor, 
which is identified as the parameter related to the effective polarizability of the particle: 
 𝐶𝑀 = ,Yc,d,Ye#,d (2-13) 
In real systems, both the suspended particles and medium exhibit conductivity. 
When AC fields are applied, modifications need to be made in the CM expression 
because of these conduction losses, in the form of complex permittivity 𝜀∗  or 
conductivity 𝜎∗ [22]: 
 𝜀[∗ = 𝜀[ − hiYj  (2-14) 
 𝜎[∗ = 𝜎[ + 𝑖𝜔𝜀[ (2-15) 
where 𝑖 is the imaginary vector (𝑖 = −1) and 𝜔 is the angular frequency (𝜔 = 2𝜋𝑓) of 
the applied field. Then, the corresponding CM factor can be expressed as: 
 𝐶𝑀∗ = ,Y∗c,d∗,Y∗e#,d∗  (2-16) 
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Or, 
 𝐶𝑀∗ = iY∗cid∗iY∗e#id∗  (2-17) 
The work presented in this dissertation only utilizes direct current (DC) electric 
fields, the angular frequency 𝜔 equals zero. Accordingly, the CM factor is expressed as 
below: 
 𝐶𝑀 = iYcidiYe#id (2-18) 
 
 
Figure 2-7. Schematic illustration of dielectrophoresis for a dielectric particle in a non-
uniform DC electric field. The inhomogeneous electric field is created by two electrodes 
with different geometry, shown in gray with indicated potential applied. The black 
dashed lines are representative of the electric field lines. Particles exhibit a higher 
polarizability (𝜀[ > 𝜀_) will show positive DEP, being pulled to higher electric field 
strength under DEP force. For the particles that are less polarizable (𝜀[ < 𝜀_ ) and 
represents negative DEP, the DEP force will withdraw the particles to lower electric field 
strength. The sign of the electrode potential can be switched without changing the DEP 
property of the particle. 
 
In this situation, the sign of DEP force, which also indicates the direction of a 
particle’s motion resulting from DEP, will be determined by the relative magnitudes of 
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the conductivities of the particle and the medium. When the particle exhibits a higher 
conductivity compared with that of the medium, it will move towards regions of higher 
electric field strength upon DEP, which is termed positive DEP (pDEP). For a particle 
with lower conductivity than that of the medium, 𝑭%AL will push the particle away from 
the high electric field region, which is termed negative DEP (nDEP). Both DEP 
behaviors are shown in Fig. 2-7.  
Similar to previous derivation (Eqs. 2-4, 2-5, 2-6, 2-7) of electrophoretic velocity 𝒗AL, the DEP force on a spherical particle can be derived by its balance with the drag 
force, i.e. 𝑭%AL + 𝑭M = 0 . Dielectrophoretic velocity can be expressed in a similar 
manner [23]:  
 𝒗%AL = −𝒗 = −#V,d9qrst𝑬3UVD9 = − ,d93rsZD 𝛻𝑬# (2-19) 
Accordingly, the dielectrophoretic mobility 𝜇%AL is defined as: 
 𝜇%AL = 𝒗GWtA3 = − ,d93rsZD  (2-20) 
2.4.2 Ellipsoids 
Bioparticle in filamentous shape (bacteriophage M13 in Chapter 4) will also be 
discussed in this dissertation. In this case, the shape can be approximated to a prolate 
ellipsoid with 𝑎 ≫ 𝑏 = 𝑐 (shown in Fig. 2-8). Assuming the applied field E is parallel to 
axis x, the DEP force on this particle can be expressed as [24]: 
 𝑭%AL = #Vz>{Z 𝜀_𝑅𝑒 ,Y∗c,d∗,d∗ ∇𝑬# (2-21) 
Considering the work presented in this dissertation only utilizes DC fields, the 
equation can be further derived as previous (Eqs. 2-13, 2-14, 2-15, 2-16, 2-17, 2-18): 
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  𝑭%AL = #Vz>{Z 𝜀_(iYcidid )∇𝑬# (2-22) 
 
 
Figure 2-8: Illustration of a prolate ellipsoid with radius of a, b, c along axis x, y, z, 
respectively.  
 
2.4.3 Characteristics of Dielectrophoresis 
The above derivation of related equations and definition of physical properties 
give insight on some important and distinct characteristics of DEP compared to EP. First 
and the most easily recognized aspect is that the object does not have to be charged.  This 
expands the applicable range of DEP to almost any particles or materials. Besides, DEP 
can be created by both AC and DC fields, which can be adjusted and optimized to reach 
the best experimental condition for the manipulation of different objects. Meanwhile, 
DEP is a ponderomotive effect [22] from its expression, which means that it is particle-
volume dependent. According to this relationship, the DEP force scales with size of the 
object. For particles that are not a perfect sphere, the variations in their size, shape and 
even composition will lead to completely different DEP properties. The required non-
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uniform electric field for DEP can be induced using different methods, such as electrodes 
array or different insulator shapes.  
 
2.5 The g-iDEP System 
Microfluidic devices can provide an alternative and likely more efficient method 
for bioparticle separation by incorporation of micron-sized channels. This approach is 
explored here using the sawtooth-patterned gradient insulator-based DEP (g-iDEP) 
device. This technique was first introduced in 2007, featuring progressive changes in the 
tooth geometry which can create distinct zones of increasing local field gradient along the 
length of the channel [12].  
The specific details of the first design (V1 channel, Fig. 2-9) were introduced by 
Staton et al [25]. The dimensions of the channel were designed by changing the size of 
the insulating 60-degree-triangles, which started with 6 μm for base-length and 5.2 μm 
height. From inlet to outlet, the gate size (closest distance between the constriction at 
each pair of sawteeth) is decreased gradually from initial 945 µm to final 27 µm by 
increasing the side length and width of each PDMS triangles by 40 µm after every 6 
repeats. It has demonstrated isolation and concentration of polystyrene particles [25], red 
blood cells [26], amyloid fibrils [27], Escherichia coli serotypes [28], and Staphylococcus 
epidermidis strains [29]. However, most of the capturing phenomena were observed in 
the last two sets of gates. In order to improve the resolving capabilities of g-iDEP device 
and extend the range of capture to smaller analytes, alternations were made to a new 
channel design (V2 channel, Fig. 2-10). 
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In order to optimize the channel design, investigations have been carried out to 
establish the mechanisms of particle capture. Considering DEP is highly dependent on 
the electric field gradient, it is highly localized to where the electric field shows a high 
enough heterogeneity. Beyond these areas, other translational forces dominant the motion 
of the particle. Therefore, in order to immobilize a particle within a dielectrophoretic-
active zone, the DEP must equal or exceed all other transport mechanisms present in the 
system. This discussion here will focus on electromotive forces, assuming that DEP and 
EK are the primary contributions to particle transport. 
It can be assumed that particle immobilization is achieved when the particle flux 
(𝑱) along the field line is zero [30, 31], 
 𝑱 ∙ 𝑬 = 0 (2-23) 
 𝑱 = 𝑐(𝝊A\ + 𝝊%AL) (2-24) 
where 𝑐 is the particle concentration in the system. 
Substituting Eqs. 2-10, 2-11, 2-19, 2-20 gives the following expression: 
 𝑐(𝜇A\𝑬 + 𝜇%AL∇𝑬#) ∙ 𝑬 = 0 (2-25) 
Particle trapping occurs in locations where DEP dominates, which expands the particle 
immobilization condition to: 
 𝑐(𝜇A\𝑬 + 𝜇%AL∇𝑬#) ∙ 𝑬 ≤ 0 (2-26) 
which gives two other equations for particle immobilization by further rearrangement: 
 GW∇𝑬3∙𝑬G𝑬𝟐 ≥ 1 (2-27) 
and, 
 ∇𝑬3∙𝑬𝑬𝟐 ≥ GGW (2-28) 
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This Eq. 2-28 describes the immobilization condition of the particle in terms of 
comparing the electric field parameters to the intrinsic properties of the system (both the 
particle and the medium). It also allows for a method to estimate the capturing ability of 
the device independent of the particle and the medium.  
 
Figure 2-9. Microchannel design V1 and the corresponding characteristic value 𝑒{ along 
the centerline. The channel inlet and large gate sizes are oriented to the left, while the 
outlet and small gate sizes are oriented to the right. Specific values for 𝑒{ depend upon 
channel geometry and the applied potential (500 V for this model). Each set of gate 
consists of six geometrically equivalent gates, all with equal gate size. The corresponding 𝑒{ value shows a more exponentially increase as the gate size for each set is following a 
relatively linear decreasing trend from inlet (left) to outlet (right). The highest 𝑒{ value, 
representing the capture ability, only shows up at the last two sets of gates. This also 
matches the experimental results that most particles tried in V1 channel only show 
capture at the last two sets of gates. 
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To simplify following discussion, this field-related term ∇𝑬3∙𝑬𝑬𝟐  is expressed as 𝑒{, 
the concomitant electromotive force experienced by a particle [13, 32]. This value 
reaches a local maximum near each gate. Given knowledge of the mobility of the species 
to be analyzed, the required value of 𝑒{ can be determined. The design must, therefore, 
accommodate the achievement of this value. Modeling confirms that the original V1 
channel geometry creates values of 𝑒{  that are insufficient for the capture of small 
analytes. The relatively linear change of the gate size consequently causes most of the 
capturing phenomena to be observed in the last two sets of gates [25-29].	 Even relatively 
large species are only captured near the final set of gates, where the highest maxima of 𝑒{ 
occurs. Furthermore, the magnitudes of local maxima in 𝑒{  increases exponentially at 
gates along the V1 channel (Fig. 2-9). This leads to minimal variation in 𝑒{ along most of 
the channel length, and thus reduces capacity for resolving different analytes.	
In an effort to iteratively improve the capability and applicability of g-iDEP 
device, new micro channels (V2 channel) were designed. This work is primarily lead and 
driven by Dr. Jones [13, 32]. The final gate sizes were determined from previous 
experimental result and corresponding finite elements multiphysics simulation. Two 
primary concerns were the improvement of g-iDEP resolving capabilities and extending 
the range of capture to smaller analytes including submicron bioparticles.  One of the V2 
channel (V2L, Fig. 2-10A) was designed for use with larger particles, such as red blood 
cells and bacteria. The distance between the teeth tips at each constriction repeats every 
three, with a decreasing trend varying from 73 µm near the inlet reservoir to 25 µm near 
the outlet reservoir. The other V2 channel (V2S, Fig. 2-10B) is more designed for use 
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with small bioparticles such as viruses and proteins. It features initial and final gate sizes 
of 30 and 3 µm, respectively.  
 
Figure 2-10. Microchannel design V2 and the corresponding characteristic value 𝑒{ along 
the centerline. The channel inlet and large gate sizes are oriented to the left, while the 
outlet and small gate sizes are oriented to the right. Specific values for 𝑒{ depend upone 
channel geometry and the applied potential (500 V for this model). Each set of gate 
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consists of three geometrically equivalent gates, all with equal gate size. The gates sizes 
for each set are manually chosen and decrease from inlet (left) to outlet (right), resulting 
in a linear increase for the corresponding 𝑒{ values. (A) Microchannel V2L. It is designed 
for use with larger particles, such as red blood cells and bacteria. The gate size decreases 
from 73 µm near the inlet reservoir to 25 µm near the outlet reservoir. (B) Microchannel 
V2S. It is designed for use with small bioparticles such as viruses and proteins. It features 
initial and final gate sizes of 30 and 3 µm, respectively.  
 
In order to enable resolution of similar analytes, V2 designs also feature more 
incremental stair-steps in pitch between sets of gates (Fig. 2-10). This offers the potential 
to improve resolution of analytes by creating a series of more finely tuned and graduated 
dielectrophoretic traps. Each trap is then capable of distinguishing smaller graduations in 
particle characteristics (Δ GGW). To design these step-sizes, modeled values of 𝑒{  were 
related to gate size (𝑝) by a power function (Fig. 2-11) [32]. The specific values are 
related to additional inputs, including the applied voltage and the specific channel 
geometry. Using this data, a set of progressively decreasing 𝑝 values was calculated, that 
would yield a linear increase in the maxima of 𝑒{ across a channel. These 𝑝 values were 
calculated ranging between the desired starting and ending values, yielding a linear 
increase in the maxima of 𝑒{ across the channel. 
Models of the new channel geometry confirm a more regulated, step-wise 
increase in ∇A3A  across the centerline of the channel (Figs. 2-9 & 2-10). In the work 
presenting in this dissertation, the V2 channels are used with different bioparticles and 
corresponding applications. V2S channel is used to verify its ability for smaller particles 
while the V2L channel is used for sample pretreatment, such as protein sample 
purification. With more experiments and model simulation, the channel design can be 
further optimized for a better manipulation of designated bioparticles.  
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Figure 2-11. Centerline maxima in ec for a hypothetical sawtooth microchannel. Values 
for ec are represented as a function of p. The increase in ec with respect to p can be 
represented as a power function.  
 
 
2.6 References 
[1]  J. Pipper, M. Inoue, L.F. Ng, P. Neuzil, Y. Zhang, L. Novak, Catching bird flu in a 
droplet, Nat. Med., 13 (2007) 1259-1263. 
 
[2]  R.M. Tiggelaar, P. van Male, J.W. Berenschot, J.G.E. Gardeniers, R.E. 
Oosterbroek, M. de Croon, J.C. Schouten, A. van den Berg, M.C. Elwenspoek, 
Fabrication of a high-temperature microreactor with integrated heater and sensor 
patterns on an ultrathin silicon membrane, Sens. Actuators A Phys., 119 (2005) 
196-205. 
 
[3]  A. Manz, N. Graber, H.M. Widmer, Miniaturized total chemical-analysis systems-a 
novel concept for chemical sensing, Sens. Actuator B-Chem., 1 (1990) 244-248. 
 
[4]  J. Siegrist, R. Gorkin, M. Bastien, G. Stewart, R. Peytavi, H. Kido, M. Bergeron, M. 
Madou, Validation of a centrifugal microfluidic sample lysis and homogenization 
platform for nucleic acid extraction with clinical samples, Lab Chip, 10 (2010) 363-
371. 
 
[5]  R. Pelton, Bioactive paper provides a low-cost platform for diagnostics, Trac-
Trends Anal. Chem., 28 (2009) 925-942. 
	 38 
 
[6]  W. Zhao, A. van der Berg, Lab on paper, Lab Chip, 8 (2008) 1988-1991. 
 
[7]  Y. Xia, G.M. Whitesides, Soft lithography, Annu. Rev. Mater. Sci., 28 (1998) 153-
184. 
 
[8]  J.C. McDonald, G.M. Whitesides, Poly(dimethylsiloxane) as a material for 
fabricating microfluidic devices, Acc. Chem. Res., 35 (2002) 491-499. 
 
[9]  R.J. Jackman, J.L. Wilbur, G.M. Whitesides, Fabrication of submicrometer features 
on curved substrates by microcontact printing, Science, 269 (1995) 664-666. 
 
[10]  M.A. Schmidt, Wafer-to-wafer bonding for microstructure formation, Proc. IEEE, 
86 (1998) 1575-1585. 
 
[11]  D.C. Duffy, J.C. McDonald, O.J. Schueller, G.M. Whitesides, Rapid prototyping of 
microfluidic systems in poly(dimethylsiloxane), Anal. Chem., 70 (1998) 4974-
4984. 
 
[12]  M.D. Pysher, M.A. Hayes, Electrophoretic and dielectrophoretic field gradient 
technique for separating bioparticles, Anal. Chem., 79 (2007) 4552-4557. 
 
[13]  J. Ding, R.M. Lawrence, P.V. Jones, B.G. Hogue, M.A. Hayes, Concentration of 
Sindbis virus with optimized gradient insulator-based dielectrophoresis, Analyst, 
141 (2016) 1997-2008. 
 
[14]  F.F. Reuss, Sur un nouvel effet de l'électricité galvanique, Mem. Soc. Imp. Nat. 
Moscou., 2 (1809) 327-327. 
 
[15]  X. Ren, M. Bachman, C. Sims, G.P. Li, N. Allbritton, Electroosmotic properties of 
microfluidic channels composed of poly(dimethylsiloxane), J. Chromatogr. B, 762 
(2001) 117-125. 
 
[16]  D. Erickson, Electroosmotic flow (DC), in: D. Li (Ed.) Encyclopedia of 
Microfluidics and Nanofluidics, Springer US, Boston, MA, 2013, pp. 1-11. 
 
[17]  W.B. Russel, D.A. Saville, W.R. Schowalter, Colloidal dispersions, Cambridge 
University Press, Cambridge;New York;, 1989. 
 
[18]  R.J. Hunter, Foundations of colloid science, Oxford University Press, Oxford;New 
York;, 2001. 
 
[19]  M.V. Smoluchowski, Contribution to the theory of electro-osmosis and related 
phenomena, Bull. Int. Acad. Sci. Cracovie, 3 (1903) 184-199. 
 
	 39 
[20]  E. Huckel, Die Kataphorese der Kugel, Physik Z, 25 (1924) 204-210. 
 
[21]  H.A. Pohl, The motion and precipitation of suspensoids in divergent electric fields, 
J. Appl. Phys., 22 (1951) 869-871. 
 
[22]  R. Pethig, Review Article-Dielectrophoresis: Status of the theory, technology, and 
applications, Biomicrofluidics, 4 (2010) 022811. 
 
[23]  S. Dash, S. Mohanty, Dielectrophoretic separation of micron and submicron 
particles: a review, Electrophoresis, 35 (2014) 2656-2672. 
 
[24]  H. Morgan, N.G. Green, Dielectrophoretic manipulation of rod-shaped viral 
particles, J. Electrostat., 42 (1997) 279-293. 
 
[25]  S.J.R. Staton, K.P. Chen, T.J. Taylor, J.R. Pacheco, M.A. Hayes, Characterization 
of particle capture in a sawtooth patterned insulating electrokinetic microfluidic 
device, Electrophoresis, 31 (2010) 3634-3641. 
 
[26]  P.V. Jones, S.J. Staton, M.A. Hayes, Blood cell capture in a sawtooth 
dielectrophoretic microchannel, Anal. Bioanal. Chem., 401 (2011) 2103-2111. 
 
[27]  S.J.R. Staton, P.V. Jones, G. Ku, S.D. Gilman, I. Kheterpal, M.A. Hayes, 
Manipulation and capture of Aβ amyloid fibrils and monomers by DC insulator 
gradient dielectrophoresis (DC-iGDEP), Analyst, 137 (2012) 3227-3229. 
 
[28]  P.V. Jones, A.F. DeMichele, L. Kemp, M.A. Hayes, Differentiation of Escherichia 
coli serotypes using DC gradient insulator dielectrophoresis, Anal. Bioanal. Chem., 
406 (2014) 183-192. 
 
[29]  P.V. Jones, S. Huey, P. Davis, R. McLemore, A. McLaren, M.A. Hayes, 
Biophysical separation of Staphylococcus epidermidis strains based on antibiotic 
resistance, Analyst, 140 (2015) 5152-5161. 
 
[30]  A. LaLonde, A. Gencoglu, M.F. Romero-Creel, K.S. Koppula, B.H. Lapizco-
Encinas, Effect of insulating posts geometry on particle manipulation in insulator 
based dielectrophoretic devices, J. Chromatogr. A, 1344 (2014) 99-108. 
 
[31]  A. Gencoglu, D. Olney, A. LaLonde, K.S. Koppula, B.H. Lapizco-Encinas, 
Dynamic microparticle manipulation with an electroosmotic flow gradient in low-
frequency alternating current dielectrophoresis, Electrophoresis, 35 (2014) 362-373. 
 
[32]  P.V. Jones, Development of a new approach to biophysical separations using 
dielectrophoresis, in:  School of Molecular Sciences, vol. Doctor of Philosophy, 
2015, pp. 176. 	  
	 40 
CHAPTER 3	
CONCENTRATION OF SINDBIS VIRUS WITH OPTIMIZED GRADIENT 
INSULATOR-BASED DIELECTROPHORESIS 
 
3.1 Introduction 
Detection, isolation, and identification of viruses are key steps in the diagnosis of 
the infectious disease and are prerequisites for research that leads to vaccine, treatments, 
and therapies [1-4]. 
The initial indicator of a viral infection is generally made by observation of 
symptoms by the host. Establishing the virological cause can require a lengthy diagnostic 
process, particularly if the causative virus is rare. The early detection methods relied on 
demonstration of infection in a susceptible host, including animals, embryonated eggs, 
organ cultures or plants [5, 6]. Among various biological and physical approaches, plaque 
assay is the most elegant, quantitative and useful one. It was developed in the early 1900s 
for the study of bacteriophage [7]. However, the measured presence of infectivity doesn’t 
necessarily correspond to the number of virus particles in a preparation and some viruses 
require cells in distinct states [5]. In response, focus assay based on transformation 
cytopathology [8, 9] and the endpoint-dilution assay based on detectable pathology [10] 
were developed. These methods still have long analysis times (up to 4 weeks), relatively 
poor sensitivity and are susceptible to bacterial contamination. 
Serological methods based on antibody-antigen recognition are a mainstay 
of viral diagnosis today and include immunofluorescence techniques [11-13], 
enzyme linked immunosorbent assay [14-16], western blot [17-19], green 
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fluorescent protein [20], and a host of other less common approaches. Nucleic 
acid-based assays that rely on polymerase chain reaction (PCR) methods are 
commonly used both for identification and quantification of viruses [21]. DNA 
microarrays and high-throughput sequencing methods can positively identify an 
unknown viral pathogen [22]. For many of these techniques, the sensitivity and 
specificity depend greatly on the choice of antigen or target sequence and detection 
reagents, including antibodies and specific nucleic acid probes.  
Direct assays include electron microscopy (EM) methods to observe the 
morphology of viruses or EM immuno-based detection of viruses [23]. However, 
considering that most viruses share similar rod or icosahedral morphologies, 
common transmission electron microscopy (TEM) is not sensitive enough to 
produce the high-resolution images needed for identification. Cryo-EM is capable 
of producing the near atomic-level resolution of virus constructions without 
chemically altering original viral structures [24, 25]. However, this technique is 
limited by the requisite concentrated sample [5] and the extensive amount of time 
and resources that are required to produce high resolution images. It is not feasible 
to discern all viruses from morphological data alone even when high quality 
images are obtained.   
Isolation and purification of a virus from its host require another set of 
techniques including column chromatography, centrifugation, and microfluidics 
[26-34]. Centrifugation is a classic, powerful, and common technique for 
separation and purification of bioparticles.  But it does have some limitations, 
including low efficiency for separating particles with similar density, such as 
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proteins and viruses [26]. Separation techniques based on membrane systems were 
developed in the last 30 years and are still attracting considerable attention [27, 
28]. The membrane system is suitable for large-scale processes and the efficiency 
is highly dependent on the affinity of targets to specific membranes. Also, the pore 
size of membranes is a sensitive variable that affects efficient separation. 
Chromatographic methods, such as size exclusion and ion exchange, are 
also used to separate and purify viruses based on differences in size and charge 
characteristics [29, 30]. Similar to membrane separation techniques, these are used 
for large-scale preparations and suffer from low efficiency and selectivity 
challenges, due to the limited pore size choices.  
Separation techniques based on microfluidics show great potential for practical 
application of virus isolation [31-34]. Microfluidic systems can enable identification, 
isolation and quantification of a virus in a single technique, which allows for small 
sample size, rapid detection, high sensitivity and short processing time. Recently, quite a 
few advanced microfluidic techniques, such as dielectrophoresis (DEP)-based ones, have 
been developed and applied to separation of viruses. 
Dielectrophoresis-based virus analysis was first explored in 1996, when 
Muller et al. [35] examined the trapping and enrichment of viruses in aqueous 
environment while the corresponding theory and simulation were accomplished by 
Schenelle et al. [36]. This successful trial extended the size limit of DEP 
manipulation to the submicron level and provided an initial example of DEP 
application for virus isolation and detection. For the following decade, more AC-
electrode DEP-based microdevices were developed for plant viruses and relatively 
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large animal viruses, including tobacco mosaic virus (TMV) [37-39] and herpes 
simplex virus (HSV) [39-42]. Unique DEP properties allowed successful 
separation of TMV and HSV under AC-DEP conditions [39]. To overcome 
potential disadvantages of AC-DEP, improvements with AC-electroosmotic flow 
approaches have resulted in higher throughput of the concentrated virus [43]. 
DC-insulator-based DEP devices were introduced with their advantages of easier 
fabrication, more robust operation and a chemically inert environment. It was applied to 
viruses in 2003, when Lapizco-Encinas and her colleagues [44] first observed the 
trapping and streaming of bacteriophage T4. After that, TMV was also manipulated with 
the same strategy [45]. A similar DEP technique was recently used to concentrate 
influenza virus particles to facilitate trapping of a single particle with optical tweezers 
and subsequent infection of a cell with the isolated virus [46]. 
Incorporation of micron-sized channels in microfluidic devices can provide an 
alternative, perhaps more efficient and power-saving method for virus detection and 
separation. This approach is explored here using the sawtooth-patterned gradient 
insulator-based DEP (g-iDEP) device. This technique was first introduced in 2007 (V1, 
Fig. 2-9) [47]. The details of the previous design (V1) was introduced by Staton et al. 
[48]. Even though demonstrated isolation and concentration of some different particles 
were made [48-52], the relatively linear change of the physical size of the gates caused 
most of the capturing phenomena to be observed in the last two sets of gates and no 
capture for submicron particles. A new generation of the channel design has been 
developed (V2S, Fig. 2-10B). One of the primary concerns is to extend the range of 
capture to smaller analytes including submicron bioparticles.  
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Sindbis virus (SINV) was used as the model to test this new channel design 
(V2S). The virus is a member of the Togaviridae family that includes a number of 
medically important viruses that infect humans and other animals. SINV is 
transmitted by mosquitoes [53]. The virus is an enveloped icosahedrally structured 
with a ~70 nm diameter [54]. The virus is composed of three major structural 
components, two glycoproteins (E1 and E2) and a capsid protein [55]. The E1 and 
E2 proteins form heterodimers that associate as 80 trimers and are anchored in the 
lipid envelope [56]. Inside the envelope, 240 capsid proteins are assembled as an 
icosahedron that surrounds the ~11.7 kb positive sense, single-stranded RNA 
genome. Protein, RNA and lipids make up roughly 64%, 9%, and 27% 
respectively, of the total mass of SINV particles [54]. The near-spherical structure 
also makes it a good model for testing in DEP systems, since most theories are 
based on using the spherical target as default. Considering all these, Sindbis virus 
is used as a representative virus with a relatively small size and a near-spherical 
icosahedral structure in this work.  
In this research here, it is demonstrated for the first time that a heat resistant 
strain of Sindbis virus (SVHR) is captured using an evolved g-iDEP device (Fig. 
3-1). This device was designed and fabricated specifically for capturing submicron 
bioparticles and demonstrated isolation and concentration of SVHR. Under the 
specific experimental condition, SVHR behaves as positive dielectrophoresis 
(pDEP) particle, which is different from most of previous related group work with 
other bioparticles, such as bacteria and red blood cells [49, 51, 52]. The SVHR 
responded to applied voltage as low as 70 V, easily accessible with most power 
	 45 
supplies. Further investigation on the reproducible accumulation phenomenon 
indicates that higher applied voltage and longer time period would facilitate 
increased concentration of SVHR in the capturing zone.  
 
Figure 3-1. Illustration of the optimized sawtooth gradient insulator-based 
dielectrophoretic device (V2S). Top figure shows the side view (Top), while the bottom 
figure shows the device in vertical view. The device is approximately 4 cm long, with a 
500-µm wide, 20-µm deep open channel between two reservoirs with electrodes. The 
channel is constricted to an increasing degree by triangular insulting wall protrusions. 
These structures induce local increases in electric fields and gradients, providing 
capturing zones of increasing strength. 
 
3.2 Materials and Methods 
3.2.1 Sindbis Virus Preparation and Characterization 
A heat resistant strain of Sindbis virus (SVHR) was cultivated as previously 
described by Hernandez et al. [57] by Dr. Lawrence. Briefly, baby hamster kidney 
(BHK) cells were grown in minimal essential medium supplemented with 5% fetal 
bovine serum, 5% tryptose phosphate broth, 2mM L-glutamine, and 50 µg/mL 
gentamycin. Cells were grown to near confluence before infection with SVHR at a 
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multiplicity of infection of 0.1. Infected cells were further incubated in Glasgow minimal 
essential medium containing the same supplements as the MEM media, plus an additional 
2 g/L of NaHCO3. At 26 h after infection, the medium was removed from infected cells 
and clarified by centrifugation for 10 min at 1000g to remove cell debris. 
Harvested virus colloid was purified by centrifugation through two gradients 
prepared from potassium tartrate (dibasic hemihydrate) dissolved in PN buffer (100 mM 
NaCl, 50 mM PIPES, pH = 7.2). First, the clarified medium was sedimented on a 
continuous 15-37% potassium tartrate density gradient. Gradients were fractionated and 
the appropriated density fractions containing virus were pooled. The pooled fractions 
were with PN buffer and overlayed onto a step gradient consisting of 37% potassium 
tartrate overlayed with 15% potassium tartrate. Virus was collected from the gradient 
interface by fractionation. Both gradients were centrifuged at 100 000g for 4 h at 4 °C. 
Following gradient purification, the virus was dialyzed in PN buffer to remove potassium 
tartrate. The purified virus was inactivated by addition of glutaraldehyde to a final 
concentration of 0.01% v/v and incubating at 4 °C for 24 h. Dialysis was repeated to 
remove the glutaraldehyde. The concentration of purified virus was determined using a 
modified Lowry Assay adapted for membrane protein determination [58]. A 
concentration of 1 mg/mL of SVHR was equated to 3 × 1011 plaque forming units (pfu) 
per mL, based on corresponding plaque assays of non-inactivated SVHR in BHK cells. 
The methods for titration by plaque assay were carried out according to Hernandez et al. 
[57]. 
3.2.2 Labeling Virus with Fluorophore (Rhodamine) 
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Inactivated SVHR was suspended in PN buffer, mixed with NHS-Rhodamine 
(Thermo Scientific, Rockford, IL, USA) solution and incubated at 4 °C overnight for 
labeling reaction. Excess dye was removed by pelleting the virus at 100 000g in a 
SW55Ti rotor (Beckman Coulter Inc., Brea, CA, USA) for two hours.  The pellet was 
washed twice through resuspension and repelleting prior to final resuspension in 10 mM 
NaCl, 10 mM PIPES, pH = 7.2. For some experiments, the virus colloid was dialyzed at 4 
°C using a 3500 MWCO Slide-A-lyzer mini cassette (Thermo Scientific, Rockford, IL, 
USA). The conductivity of the buffer was measured to be 2.12 mS/cm (Traceable 
conductivity meter, Fisher Scientific, Hampton, NH, USA) The final estimated 
concentration of SVHR was 0.375-1.5 × 1011 pfu/mL, based on the original titer that was 
determined by plaque assay and losses during preparation. 
3.2.3 Characterization of Labeled Virus 
Dynamic light scattering (DLS) and transmission electron microscopy (TEM) 
were used to determine the size distribution and confirm intact morphology of virus, 
respectively, before and after labeling. DLS measurements were carried out with a 
Spectro Size 302 (Molecular Dimensions, UK), equipped with a 785 nm laser. For each 
measurement, the laser was directed at a 3-5 µL hanging droplet of the sample suspended 
from a siliconized glass cover slide. Data was compiled from ten separate 20 s 
measurements. Settings included a shape factor of 1.0, exponent of 3.0, and refractive 
index of 1.339. Correlation of the resulting signal to the sample was validated by a 
sigmoidal autocorrelation function. A narrow size distribution is indicative of a 
monodispersed sample. TEM was carried out with beam energy of 80 kV. Virus (5 µL) 
was spotted onto 300-mesh copper grids with formvar support film (Electron Microscopy 
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Sciences) and incubated for 5 min. The grid was blotted dry and negatively stained with 5 
µL of 2 % uranyl acetate. The grid was again blotted dry prior to imaging.  
3.2.4. Device Fabrication 
The microfluidic device was fabricated by an established procedure of 
photolithography, fabrication, and bonding techniques [59]. The channel configuration 
was first designed using Adobe Illustrator (Adobe Systems Inc., San Jose, CA) and 
printed onto a chrome-glass photomask (J D Photo-Tools LTD, Oldham, Lancashire, 
UK). With the photomask, a silicon wafer was then made using photolithography and dry 
etching techniques. PDMS casts were made from the silicon wafer using a Sylgard 184 
silicone elastomer kit (Dow Corning Corp., Midland, MI, USA). Access holes were 
created with a 3 mm Harris Uni-Core punch (Shunderson Communications Inc., Orleans, 
Ontario, Canada). PDMS casts were washed with isopropanol and water and, then, 
sonicated for 30 s (Aquasonic ultrasonic cleasner, VWR International, Radnor, PA, 
USA). Glass slides were washed with acetone, isopropanol, and water successively 
before being sonicated for 10 s. The PDMS casts and glass slides were dried with N2 gas 
and treated with high level O2 plasma (Plasma Cleaner, Harrick Plasma, Ithaca, NY, 
USA) for 60 s before contact sealing. 
The design of V2S g-iDEP device is developed for generating linear gradient for 
tooth-to-tooth of ∇𝑬3𝑬  ratio (𝑒{ mentioned in Chapter 2), and for smaller bioparticles, such 
as viruses and proteins. Generally, the device has two reservoirs on both ends of the 
channel into which electrodes are placed and connected to the power supply (Fig. 3-1). 
The central part of the channel is constructed of 24 sawtooth shaped constrictions. The 
distance between the sawtooth tips at each constriction repeats every three with a 
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decreasing trend varying from 30 µm near the inlet reservoir (left) to 3 µm near the outlet 
reservoir (right). These specific size of constriction between each pair of sawteeth was 
optimized for achieving linear trend line of 𝑒{ on the centreline of the gates for better 
resolving ability.  
3.2.5 Experimental Procedure 
The internal channel of the device was rinsed with running buffer (10 mM NaCl, 
10 mM PIPES, pH = 7.2) and treated with 4 mg/mL BSA to reduce electroosmosis and 
nonspecific adsorption. A 10 µL aliquot of labeled virus was introduced into the inlet 
reservoir, closest to the largest gate (Gate 1 in Fig. 3-1), using micropipette. Running 
buffer was added in the outlet reservoir to eliminate the pressure driven flow. Two 
platinum wire electrodes (0.25 mm diameter, 99.997% purity, Alfa Aesar, Ward Hill, 
MA, USA) were placed, one in each reservoir, with both connected to a high voltage 
power supply (HVS 448 High Voltage Sequencers, LabSmith Inc., Livermore, CA, 
USA). The sample solution was introduced into the microchannel through the inlet 
reservoir and was allowed to flow until several channel volumes had passed, assuring 
viral particles are evenly distributed throughout the whole channel. The electrical 
potential was applied across the microchannel (Vapp), ranging from 0-700 V, while the 
behavior of viral particles was examined throughout the whole channel. The applied 
voltage time varied from a few seconds up to one minute for multiple experiments and 
sample preparations. 
3.2.6 Data Collection and Analysis 
The SVHR behavior in the DEP device was monitored using an Olympus IX70 
inverted microscope in epi-fluorescence configuration. Light was detected with a 
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QICAM CCD camera (Q Imaging, Surrey, British Columbia, Canada) and recorded using 
a commercial program (Stream Pix V program, NorPix, Montreal, Quebec, Canada). 
Further image processing was performed using Image J (U.S. National Institutes of 
Health, Bethesda, Maryland, USA). 
3.2.7 Safety Consideration 
SVHR is a biosafety level (BSL) II agent. All procedures were performed in BSL 
II approved space. 
 
3.3 Results 
3.3.1 Characterization of Sindbis Virus 
The target virus, SVHR, was characterized for size and morphology, before and 
after labeling treatment (Fig. 3-2). DLS was performed to define the size distribution of 
the unlabeled particles. A large majority of the SVHR particles are shown to have a 
radius of about 46 nm, with some particles a bit smaller or larger, which might be the 
fragments of broken viruses or the aggregated viral particles caused by these fragments 
(Fig. 3-2A). After labeling, SVHR had a narrower distribution of size (Fig. 3-2B), but 
centered at a higher radius of 56 nm. These values reasonably agree with the theoretical 
radius of SVHR (r = 34 nm [60]) considering that the size measured from DLS is the 
equivalent hydrodynamic radius, which is usually larger than the actual physical radius. 
The heat maps of the light scattering intensity corresponding to the SVHR sample before 
and after labeling were also examined (Fig. 3-2C and D). The scattered light intensity is 
mainly from viral particles with restricted size range throughout the measuring period. 
The narrow distribution and consistent results are indications of no significant 
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aggregation of virus, which shows that the SVHR sample is in a highly monodispersed 
state. 
	
Figure 3-2. Characterization of SVHR viral particles by DLS and TEM before and after 
labeling. Size analysis by DLS measurement: histogram of size distribution (A, before 
and B, after) and heat maps (C, before and D, after). Histogram data indicates viral 
particles average 46.3 nm before labeling and 56.4 nm after. Heat maps provide temporal 
information for ten separate 20 s measurement that can detect polydispersity (blue for 
lowest intensity and red for highest). Data indicate a monodisperse population and a shift 
to larger size for labeled population. Visual inspection before (E) and after (F) labeling 
was recorded via TEM. The shape of the virions vary little, presenting a semispherical 
outline for both populations. Size estimation from 100 particle features from each figure 
confirms uniformity, with the labeled virus slightly larger-in agreement with the DLS 
results. 
 
Transmission electron microscopy also produced unambiguous results. Individual 
light grey circular structures, surrounded by diffuse darker rings, were apparent 
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throughout all images (Fig. 3-2E and F). Few or no broken circles or joined, irregular 
features, consistent with damage or aggregation were noted. There were no significant 
morphological or size changes between the two samples and the diameter from 100 
circular structures (for each sample) was 69.2 ± 4.4 nm (unlabeled) and 69.6 ± 4.3 nm 
(labeled). The result (Table 3-1) shows a good agreement with the literature report [60]. 
 
3.3.2 Dielectrophoretic Capture of Sindbis Virus 
The labeled SVHR was injected into the g-iDEP devices. The gates with a gap 
width of 3.3 µm demonstrated consistent visible capture for all trials (without obvious 
errors such as bubbles or clogging). The 20th gate, which is the middle gate of the set of 
three, was chosen for detailed quantitative assessment (Fig. 3-3) since it was not the last 
set of gates and capture occurred at low voltage. These studies were captured with 
fluorescence imaging and combined light-field and dark-field illuminations. Before the 
voltage was applied, the SVHR sample solution was evenly distributed throughout the 
whole channel and no obvious fluorescence was seen in the channel (Fig. 3-3A). Upon 
application of the voltage, viral particles began moving towards the outlet reservoir and 
simultaneously began to trap and thus accumulated at the outlet side (right side) of the 
gate. Over the application of Vapp for 15 s, clear increase in fluorescence intensity can be 
observed within the capturing zone (Fig. 3-3B). Considering that the dominant movement 
in the microchannel is the electrokinetic flow towards the outlet (blue arrows in Fig. 3-
Table 3-1. Size of Sindbis Virus Determined by DLS and TEM	
Sample DLS (rvirus) TEM (rvirus) 
Original virus 46.3 ± 2.1 nm 34.6 ± 2.2 nm 
Labeled virus 56.4 ± 1.7 nm 34.8 ± 2.2 nm 	
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3B), the capture at the outlet side of the gate is consistent with the positive 
dielectrophoresis (white arrows in Fig. 3-3B). No accumulation is observed at the inlet or 
left side of the gate. Electrokinetic and dielectrophoretic forces are additive in this zone 
and the particles are accelerated. After removing the voltage, the viral particles released 
and are observed to diffuse to the surrounding solution (Fig. 3-3C). 
	
Figure 3-3. Images of virus accumulation and release at gate 20. (A) Even distribution of 
viral particles. No obvious fluorescence is detectable near the constriction prior to 
application of the voltage. (B) After 15 s with 300 V applied on the whole channel, there 
is clear accumulation of the fluorescent particles on the outlet side (right side) of the gate, 
represented as a constricted peak in the capturing zone in the corresponding fluorescence 
profile. Blue arrows indicate the direction of electrokinetic forces, while the white arrows 
are the directions of pDEP force. (C) Captured particles diffused away upon the removal 
of the voltage. Most fluorescence disappears at the region of capture. The surface plots on 
the right are the fluorescence intensity profiles of the area in the corresponding red boxes 
in the images.  
 
The applied voltage was varied from 100 V to 600 V with 100 V increments (Fig. 
3-4). Integrated fluorescence intensity (FI) was measured at the capture region for each 
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value. FI increased rapidly with time for values of above 200 V (Fig. 3-4A). Intensity 
measurements were taken at time point 20 s, when Vapp had been on for 15 s (Fig. 3-4B), 
where FI increases dramatically with the increased Vapp. All FI measurements were 
acquired after applying Vapp for the same period of time (15 s), indicating higher values of 
Vapp result in faster accumulation of viral particles. The virions are transported and 
accumulated faster since local velocity is 𝒗AL = 𝜇AL𝑬  (rearrangement of Eq. 2-8 in 
Chapter 2) and 𝑬 is a direct function of Vapp. This behavior has been verified with a 
simplified model of virus transportation and accumulation (See Supplemental Fig. 3-
S1,2,3,4,5) 
 
Figure 3-4. Data analysis of SVHR behavior at gate 20 with different Vapp in one trial. 
The gate size is 3.3 µm at G20. The concentration of SVHR is 1.5 × 1011 pfu/mL. (A) 
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Real-time monitoring of integrated FI increase versus time with Vapp from 100 V to 600 
V. (B) The integrated FI of the capturing zone with Vapp being on for the duration of 15 s, 
replot from the data at 20 s time point in A (indicated by the dashed line in A) at each 
Vapp. Error bars are based on the ten data points for ± 0.5 s.  
 
The behavior of virus in the g-iDEP device indicated that there was a potential 
transition from noncapturing to capturing when moving to higher Vapp. To examine this 
transition, Vapp was varied between 0 and 100 V at a smaller increment of 10 V and the FI 
was investigated (Fig. 3-5). Combining with the results obtained at higher Vapp (>100 V), 
data consistently generates a pattern of three stages: no obvious capture at low Vapp 
(≲50–70 V), steadily rising FI with increasing voltage (∼70 to 200 V) where significant 
capture occurs, and stable FI with increasing voltage (greater than 200 V).  
 
Figure 3-5. Reproducibility of the virus capture at different Vapp at gate 20. By repeating 
the experiments with independent preparation of SVHR samples and each in a separated 
device, lower applied voltages between 0 V and 100 V were tested for more 
comprehensive understanding of the change of FI versus Vapp. The virus behavior shows 
in a stage-wise way with little or no capture at low voltages (stage I), rapid increase with 
increased Vapp (stage II) and leveling off during plateau (stage III). Error bars are the 
standard deviation (n = 3). 
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By repeating the experiments with independent preparation of SVHR samples in 
separated devices, the results demonstrated a good reproducibility of virus manipulation. 
Corresponding data analysis by comparing the fluorescent intensity change at the 
capturing zone also revealed an intensity increase of SVHR by two to six times within 15 
s (original data not shown). 
 
3.4 Discussion 
3.4.1 Behavior of Sindbis Virus in g-iDEP Device 
Using the labeled inactivated SVHR with the V2S microchannel device, capture 
and accumulation were observed and analyzed. The behavior of SVHR is consistent with 
pDEP in our channel geometry and applied field direction. Positive DEP behavior has 
been observed with other viruses noted above [31, 39, 42, 44]. 
When the potential is removed, the FI dissipates quickly, indicating that the 
trapped virions were freely diffusing even after capture and show reversible capture 
behavior. Considering ec is related to electric field and gate size, higher ec can be 
generated with increased applied voltage while gate sizes are fixed in the channel. The 
result indicates that longer time period and higher Vapp facilitate increased accumulation. 
By tuning Vapp from zero to 600 V, the behavior of virus in the device indicates there is a 
transition from zero capture (flowing through) to definitive capture (Fig. 3-5). This trend 
can generally be described by a sigmoidal shape and we term the three stages I (≲50–70 
V), II (∼70 to 200 V) and III (greater than 200 V) for discussion purposes.  
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Figure 3-6. COMSOL simulation for (A) E and (B) ∇𝐸# in the channel (using V2L as an 
example at 1500 V). The surface plot is showing the absolute value of (A) E and (B) 𝛻𝐸# 
in the whole channel while the line graph is showing the absolute vlue of (A) E and (B) 𝛻𝐸# on the centerline through the channel. 
 
Within stage I, the electrokinetic force dominates and ec is too small for capture. 
Most of the virions flow through the channel from inlet to outlet with electrokinetic flow. 
Virions may be influenced by dielectrophoretic forces and stream (lateral offset) through 
the gate areas, although neither of these actions can be explicitly observed. They are 
inferred by the actions at slightly higher voltages. However, in this low voltage range, 
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slight increase of the fluorescence intensity can still be observed with increased applied 
voltage. This could be caused by the inhomogeneous distribution of electric field along 
the vertical direction, from one tooth to its opposite tooth. The gradient of the electric 
field is much higher near the tip of the tooth, compared with the point on centerline with 
same longitudinal position (Fig. 3-6). This would initiate heterogeneous accumulating 
behavior, with some virions that travel through the space closer to tooth being trapped at 
even lower Vapp.  In order to minimize this partial capture, an improved channel design 
has been explored to achieve complete capture without attachment on the surface of the 
wall. [61]  
 
Figure 3-7. Estimation of the onset point from stage I to stage II during virus 
accumulation. A slope change can be observed with the FI data with Vapp below 200 V. 
This change can be introduced by the trapping mechanism, from local immobilization 
near sawtooth tips with high gradient of electric field (stage I) to a more complete trap of 
all viral particles traveled to the capturing zone where DEP is high enough to 
counterbalance EK (stage II). The intersection of these two fitting lines indicate an onset 
point of 68 V.  
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Within stage II, with Vapp above a certain threshold (around 70 V, Fig. 3-5), ec is 
large enough for capture. A slope change can be observed with the FI data with Vapp 
below 200 V (Fig. 3-7). This change can be introduced by the trapping mechanism, from 
local immobilization near sawtooth tips with high gradient of electric field (stage I) to a 
more complete trap of all viral particles traveled to the capturing zone where DEP is high 
enough to counterbalance EK (stage II). All virions that enter the accumulation zone are 
retained and the transport of virions increases with higher local electric field, which is 
related to Vapp. The integrated FI changes approximate a linear relationship from 80 V to 
200 V of Vapp, consistent with the electrokinetic transport and full capture mechanisms. 
Within stage III (>200 V), FI reaches a relatively stable, but noisy level. There are 
two possible mechanisms for this plateau. One is that the FI in the region of interest 
(ROI) reaches the saturation of the CCD camera. Even though more viral particles being 
transported and captured in ROI at higher Vapp, the CCD camera cannot detect the 
correspondingly increased FI, showing as a plateau (Fig. 3-5). The second possibility is 
depletion. At each gate, most virions being captured have been transported from the local 
solution on the left side of the gate. If the gate prior to the collection gate is also 
capturing virions (true at higher Vapp), then the volume where the virions could be 
collected is depleted and no further capture is possible. This is not true for temporal 
collections, as the volume available for depletion reaches into the sample reservoir. 
Corresponding data analysis also demonstrates that the concentration of SVHR was 
increased by about two to six times within 15 s with this limitation by saturation.  
3.4.2 Structural Analysis on DEP Behavior of SVHR 
	 60 
At current stage, SVHR must be labeled for real time monitoring and 
quantification. The structure and size distribution remains relatively consistent before and 
after labeling. Slightly more homogeneous size distribution is observed after labeling 
(Fig. 3-2C and D). Virus particles tend to form aggregations that settle, removing a sub-
population. The attached dye moiety may improve stability though altered 
hydrophobicity and inter-particle interactions, preventing degradation or aggregation. 
The structure of SVHR has been well studied. From outer shell to inner core, 
there are three components: a lipid bilayer embedded with glycoproteins E1 and E2 
(envelope), a protein layer (capsid) and the RNA genome core. Both envelope and capsid 
make up the icosahedral structure, which can be reasonably approximated as two 
concentric spherical shells [62]. This spherical shape simplifies the estimation of 
dielectrophoretic forces (allowing an assumption of a simple ∼70 nm [54] sphere).  
The dielectrophoretic behavior of SVHR is consistent with pDEP under the 
experimental condition. For the Clausius-Mossotti relationship to hold, conductivity of 
the particle must be larger than that of the medium (2.12 mS/cm). Among the three main 
components of SVHR, lipid bilayer in the envelope has a low conductivity (<10-8 S/m) 
and contributes little to the overall conductivity. However, the glycoproteins in the 
envelope and capsid proteins may significantly influence the overall dielectric properties 
of SVHR. The glycoproteins, E1 and E2 (embedded in the lipid bilayer) and the capsid 
are anchored together through interaction between the glycoprotein E2 endodomain with 
capsid proteins [61]. The charged residue in the proteins as well as the interaction 
between proteins from outer shell to inner core would increase the conductivity of the 
whole viral particle. Similar impact of structural proteins on the electric properties of 
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other viruses has also been demonstrated in previous research [63]. The conformational 
structure of virus changes accordingly with varying experimental conditions [62]. Noting 
all these factors, the core structure of the virus particle still has a relatively low 
conductivity compared to the buffer. Instead, the surface conductance resulting from the 
ionic double layer is the most likely contributor to the demonstrated conductivity.  
At pH = 7.2, the SVHR is negatively charged (pI = 4.2) [64]. The corresponding 
electrophoretic movement is towards the inlet reservoir, which is in the opposite direction 
with the bulk electroosmotic flow. During labeling, the dye molecule replaces the 
primary amine groups on the side chain of lysine. Estimated from a similar reaction in 
previous study [65], there will be 1320 ± 600 lysine residues on the surface exposed to 
the local environment and reacting with the dye molecule. At pH = 7.2, lysine is 
positively charged while the dye molecule has a net charge of zero. Labeled SVHR is 
more negatively charged, which would decrease the electrokinetic velocity. The relative 
high conductivity, compared with the medium, is probably because of the counter-ion 
cloud attracted to the surface of SVHR particle. The corresponding polarization of this 
counter-ion cloud would lead to an increase of the pDEP force. It is also considered to be 
associated with specific DEP behavior of DNA and other viruses in previous AC-DEP 
studies [40, 66, 67]. This is still largely speculative and dielectric properties of virus are 
in need of more experimental investigations and theoretical modeling.  
3.4.3 Application of the Method for Manipulating Submicron Bioparticles  
The capture and accumulation of SVHR in this work demonstrates the capabilities 
of using the V2S microchannel for small analytes, especially submicron bioparticles, in 
this case viral particles. According to the results, the V2S microchannel device shows 
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virus capture and release ability. More than that, the voltage-dependent capturing 
behavior is studied and a threshold voltage value is estimated. These results indicate a 
potential for clinical and diagnostic applications, where bioparticles such as cells, viruses, 
and proteins play crucial roles. Since the dielectrophoretic property varies with the 
composition, shape, size and charge of the target analyte, it is expected that different 
kinds of bioparticles would have unique dielectrophoretic behavior resulting from the 
structural variations. Instead of using conventional time-consuming methods, this rapid 
response technique would benefit clinical diagnostics in the future.  
 
3.5 Conclusions 
With the improved microchannel design (V2S) for the g-iDEP device aiming at 
submicron particles, the Sindbis virus was successfully captured under DC fields with 
easily achievable low potential.  
Previous work demonstrates the viability of using V1 microchannel for capturing 
particles, such as polystyrene particles, protein amyloid fibrils, red blood cells and 
bacteria, though most capture and concentration of particles were observed at last two 
sets of gates while all larger gates showed little evidence of capture. This improved 
design, V2S, overcomes this by creating a higher characteristic ec value increasing 
linearly throughout the channel, which realizes the capture for small particles. Further 
investigation demonstrates the reproducibility of capture and concentration Sindbis virus 
with V2S microchannel. These results bear important meaning for the future of virus 
detection and even the promising prospects of clinical analysis in fields such as point-of-
care application. 
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CHAPTER 4 
MANIPULATION OF BACTERIOPHAGE USING GRADIENT INSULATOR-
BASED DIELECTROPHORESIS DEVICE 
 
4.1 Introduction 
Bacteriophages, also known as phages, are viruses that infect bacteria. 
Bacteriophages were first discovered and identified in 1915 by William Twort and in 
1917 by Félix d'Hérelle independently, though several bacteriologists had already 
observed that bacteria could be infected and killed by a small agent [1]. Upon discovery, 
they were called “bacteriophage” from the word bacteria and the Greek word “phagein” 
which means to eat or devour. Thousands of individual bacteriophage species have been 
discovered and classified into nineteen families by the International Committee on 
Taxonomy of Viruses (ICTV) according to morphology and genomic structures [2]. 
Bacteriophages are found to be able to infect more than 140 bacterial genera, including 
aerobes, anaerobes, cyanobacteria, and spirochete [3]. They are used therapeutically for 
the treatment of infections that are resistant to antibiotics and diagnostically to identify 
pathogenic bacteria (phage typing). Another application is to kill specific bacteria found 
in food. For example, a product called LISTEXTM by Micreos is made up of 
bacteriophages that can kill the Listeria monocytogenes in food products. 
Bacteriophages are found to be extremely heterogeneous in their structural, 
physicochemical, and biological properties. However, in general, they are all composed 
of proteins that encapsulate a DNA or RNA genome. Depending on individual species, 
the bacteriophage genome can be made of either single-stranded (ss) or double-stranded 
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(ds) DNA or RNA. The vast majority contains ds-DNA, however, ss-DNA, ss-RNA, and 
ds-RNA are all found in small groups of bacteriophage. From the standpoint of structure, 
bacteriophages vary from simple to elaborate structures including the tailed, polyhedral, 
filamentous, and pleomorphic structures. The structures of two common bacteriophages 
that infect Escherichia coli (E. coli) are shown (Fig. 4-1). These two bacteriophages, T4 
and M13, are the two most widely used species in molecular biological research and 
related model studies.  
 
 
 
Figure 4-1. The structures of two common bacteriophages. (A) Bacteriophage T4. Its 
structural components are specified in the figure, including capsid, genome, collar, core, 
sheath, baseplate, tail fibers, and tail pins. (B) Bacteriophage M13. It is composed of five 
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coat proteins, 4 minor coat proteins (p3, p6, p7, and p9) and a major coat protein (p8), 
which encapsulate a circular single-stranded DNA genome. The minor coat proteins (p3, 
p6, p7, and p9) are located at two ends of the phage, while ~2700 copies of the major 
coat protein (p8) are assembled to make up the coat length of 900 nm long. See text for 
references. 
 
Bacteriophage M13 is used here because it is one of the most common 
morphologies of bacteriophage. It has been well studied from establishing its chemical 
structure to several real-world research applications. It has a filamentous shape with a 
length ~ 900 nm and a diameter ~ 6 nm. It is composed of five coat proteins, 4 minor coat 
proteins (p3, p6, p7, and p9) and a major coat protein (p8), which encapsulate a circular 
single-stranded DNA genome (Fig. 4-1B) [4, 5]. The minor coat proteins (p3, p6, p7, and 
p9) are located at two ends of the phage, while ~2700 copies of the major coat protein 
(p8) are assembled to make up the coat length of 900 nm long [6]. At one end of the 
phage, there are five copies of p9 and a companion protein, p7. At the other end of the 
phage there are five copies of the surface exposed p3 and its less exposed accessory 
protein, p6. These two proteins (p3 and p6) form the rounded tip of the phage and are the 
first proteins to interact with the host cell, i.e., E. coli, during infection. As a function of 
these properties, bacteriophage M13 shows great potential in applications such as phage 
therapy [7], phase display [8, 9], and nanotechnology [3, 10, 11]. For these applications, 
the quality of bacteriophage M13 including purity and concentration is critical and it 
relates close to the performance of the product. Therefore, a good manipulation of 
bacteriophage M13 is requisite and would facilitate these applications.  
Dielectrophoresis-based microfluidics is a powerful technique for rapid capture, 
sorting, and concentration of bioparticles and it has been utilized to manipulate 
bacteriophages. In 2013, Foram Madiyar et al. reported that bacteriophage T4 could be 
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captured using a nanostructure-based AC-DEP [12]. In the same year, Avery Sonnenberg 
et al. reported that T7 bacteriophage could be captured and isolated from whole human 
blood using a DEP microarray device [13]. Both T7 and T4 have similar structures (Fig. 
4-1A). Considering morphological and structural differences between bacteriophage 
T4/T7 and M13 (Fig. 4-1), their DEP behaviors are anticipated to differ significantly 
from each other. As there are no previous DEP-based studies focus on bacteriophage 
M13, experimentally investigating its DEP-related properties will also add another 
specific set of data and provide an example of a new morphological class of viruses. At 
the same time, this work will also support many practical applications of bacteriophage 
that require highly pure and concentrated samples. 
In the work presented in this chapter, g-iDEP device is used to manipulate 
bacteriophage M13 and investigate its biophysical properties as well. This device (V2S) 
is designed and fabricated specifically for capturing submicron bioparticles. Isolation and 
concentration of Sindbis virus was demonstrated in previous study (Chapter 3), where 
Sindbis virus is a near-spherical shape virus with a diameter of 68 nm. With filamentous 
bacteriophage M13, distinct capture and accumulation were consistently observed with 
individual device and samples from different batches. The accumulation accelerates with 
increased applied voltage. By monitoring the fluorescence intensity change on the 
longitudinal centerline across the capturing zone, the directions of EK and DEP can be 
determined. The results are consistent with the bacteriophage behaving as a negative 
dielectrophoresis (nDEP) particle under the experimental condition, which is a different 
result compared with Sindbis virus, which shows positive dielectrophoretic properties. 
An assortment of viral analytical techniques will be improved by this process, allowing 
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new fundamental studies of the viruses themselves. The work also demonstrates an 
expansion of the capabilities of g-iDEP to another example of nano-scale bioparticles, 
showing increasing diversity of targets for manipulation. This predicts the potential of 
using this g-iDEP device as a more universal application for manipulating virus particles, 
featuring different morphologies, shapes and components.  
 
4.2 Materials and Methods 
4.2.1 Bacteriophage Preparation 
Bacteriophage M13 was prepared according to the following protocol by 
collaborators in Dr. Sierks’ research group (ASU Engineering). Briefly, the 
bacteriophage were propagated according to the protocol provided in the Tomlinson I + J 
human single fold scFv (single-chain Fragment variable) libraries with VCSM13 
interference resistant helper phage [14]. Bacteriophage M13 was suspended in DPBS 
buffer (Dulbecco’s Phosphate-Buffered Saline [15], 138 mM NaCl, 8 mM Na2HPO4, 2.7 
mM KCl, 1.4 mM KH2PO4, 1 mM CaCl2, 0.5 mM MgCl2, pH = 7.4) mixed with NHS-
Rhodamin (Thermo Scientific, Rockford, IL, USA) solution and incubated at 4 °C 
overnight to label the bacteriophage. Excess dye was removed by dialyzing the 
bacteriophage colloid at 4 °C using 3500 MWCO Slide-A-lyzer mini cassette (Thermo 
Scientific, Rockford, IL, USA). The conductivity of the buffer was measured to be 15.03 
mS/cm (Traceable conductivity meter, Fisher Scientific, Hampton, NH, USA). The final 
estimated concentration of SVHR was 1.85-4 × 1010 pfu/mL considering the aggregation 
formed in the solution and losses during preparation. 
4.2.2 Device Fabrication 
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The microfluidic device was fabricated by an established procedure of 
photolithography, fabrication, and bonding techniques [16], as introduced in Chapter 3. 
The channel design used here is V2S, the same device used for Sindbis virus (Chapter 3). 
The gate size repeats every three with a decreasing trend from 30 µm near inlet to 3 µm 
near outlet. 
4.2.3 Experimental Procedure 
The experimental procedure was similar those used for Sindbis virus (Chapter 3). 
After initially treatment with DPBS solution and 4 mg/mL BSA, a 10 µL aliquot of 
labeled bacteriophage M13 was introduced into the inlet reservoir and was allowed to 
even distribution in the channel. DPBS solution was then added in the outlet reservoir to 
eliminate pressure driven flow. The electric potential was applied across the 
microchannel (Vapp), ranging from 0 to 500 V, while the behavior of bacteriophage was 
monitored. The application of voltage lasts for a few seconds each time for multiple 
experiments and sample preparations. 
4.2.4 Data Collection and Analysis 
The experimental phenomena of bacteriophage M13 were monitored using an 
Olympus IX70 inverted microscope with a ×4 or ×20 objective. Light was detected with a 
QICAM CCD camera (Q imaging, Surrey, Birtish Columbia, Canada) and recorded using 
Stream Pix V program (NorPix, Montreal, Quebec, Canada). Image J (U.S. National 
Institutes of Health, Bethesda, Maryland, USA) and MagicPlot software (Magicplot 
Systems, Saint Petersburg, Russia) were used to analyze the recorded data. 
4.2.5 Safety Consideration 
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Bacteriophage M13 is a biosafety level (BSL) I agent. All procedures were 
performed in BSL-II approved space.  
 
4.3 Results and Discussion 
4.3.1 Dielectrophoretic Capture of Bacteriophage M13 
Fluorescently labeled bacteriophage M13 was introduced into the g-iDEP device 
through injection by a micropipette. The gates with size 3.3 µm were used to demonstrate 
the visible capture consistently, without making bubbles or channel clogging. The studies 
were based on images captured with fluorescence imaging under combined light-field 
and dark-field illuminations. The bacteriophage M13 sample solution was evenly 
distributed throughout the whole channel prior to application of the electric potential, 
shown as the even fluorescence in the channel (Fig. 4-2A). Once the voltage was applied, 
the local intensity of fluorescence increased, consistent with the concentration of 
bacteriophage M13 increasing near the left side of the gate. An apparently concentrated 
region formed with the voltage applied for 15 s (Fig. 4-2B). No accumulation or increase 
of fluorescence intensity is observed on the right side of the gate (Fig. 4-2B). On the 
contrary, slight decrease of fluorescence intensity was observed in this region. After 
removal of the voltage, bacteriophage particles were apparently released and even 
distribution of fluorescence intensity was recovered in the channel (Fig. 4-2C). 
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Figure 4-2. Images of bacteriophage M13 accumulation and release. The gate size is 3.3 
µm. (A) Evenly distribution of viral particles. (B) After 15 s with 400 V applied across 
the whole channel, clear accumulation of fluorescently labeled bacteriophage M13 can be 
observed on the left side of the gate. A slightly brighter zone (arc) formed near the left 
side of the constriction, while generating a darker region on the right side. (C) Captured 
particles appeared to diffuse away upon the removal of the voltage.  
 
The value of Vapp was varied from 0 V to 400 V with 100 V increments (Fig. 4-
3A) and the average fluorescence intensity (FI) was measured at the capture region for 
each value. Intensity measurements were noted at time point 19 s, when Vapp had been 
applied for 15 s (Fig. 4-3B). The FI measurements indicated that higher FI values were 
achieved with higher Vapp applied for the same amount of time. This phenomenon is 
consistent with bacteriophage particles accumulated faster with higher values of Vapp.  
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Figure 4-3. Data analysis of SVHR behavior with different Vapp in one trial. The gate size 
is 3.3 µm. (A) Real-time monitoring of average fluorescence intensity (FI) versus time 
with Vapp from 0 V to 400 V. (B) The average FI of the capture zone with Vapp being on 
for the duration of 15 s, replot from the data at 19 s time spot in A (indicated by the 
dashed line in A) at each Vapp. Error bars are based on the 10 data points for ± 0.5 s. 
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To measure the reproducibility of this accumulation phenomenon for 
bacteriophage M13, more experiments were performed with different batches of 
bacteriophage preparation. The corresponding averaged FI at different Vapp from these 
trials were recorded (Fig. 4-4). Consistent capture and accumulation were observed in all 
these trials. The acceleration of particle accumulation with increased voltage was shown 
from the averaged data from different trials. The onset voltage of capture for 
bacteriophage M13 was estimated to be about 150 V. 
 
Figure 4-4. Reproducibility of the bacteriophage M13 capture at different Vapp at gate 20. 
By repeating the experiments with independent preparation of SVHR samples and each in 
a separated device. Error bars are the standard deviation (n=4). 
 
Using the fluorescently labeled bacteriophage M13 with the V2S microchannel 
device, capture and accumulation were observed and analyzed to determine the 
dielectrophoretic properties of bacteriophage M13. Immobilization occurs when the 
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superposition of EK and DEP equals zero (Chapter 2). Four potential combinations of the 
directions of EK and DEP are listed (Fig. 4-5). The bacteriophage M13 was captured on 
the left side of the channel, the direction of EK and DEP must be in opposition in that 
region, which is consistent with only two of the combinations (Fig. 4-5B and Fig. 4-5C). 
Further consideration of the FI change along the channel, it is clear that one of these two 
combinations (Fig. 4-5B) will also cause the FI decrease on the right side of the gate 
because both EK and DEP drive particles away from the gate. This FI decrease will not 
happen in the other mechanism (Fig. 4-5C).  
 
 
Figure 4-5. Four potential combinations of the directions of EK and DEP. (A) EK 
towards the outlet of the channel while DEP shows positive for the particle. Capture 
would happen on right side of the gate. (B) EK towards the outlet of the channel while 
DEP shows negative for the particle. Capture would happen on left side of the gate. (C) 
EK towards the inlet of the channel while DEP shows positive for the particle. Capture 
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would happen on left side of the gate. (D) EK towards the inlet of the channel while DEP 
shows positive for the particle. Capture would happen on right side of the gate. In (B) and 
(D), both EK and DEP are towards away from the gate constriction. This would lead to 
fluorescently labeled particles transporting away from gate, which will result in FI 
decrease on the other side opposite to capture zone. 
 
The FI change on the centerline across the channel was examined in detail (Fig. 4-
6). The profiles of the FI on the centerline were plotted from 4 s to 19 s with an interval 
of one second, which are the corresponding FI profiles when the application time of Vapp 
is from 0 s to 15 s with an increment of one second (Fig. 4-6). The FI decreases on the 
right side of the gate, with the increasing time of voltage application. This phenomenon is 
consistent with only one of the mechanisms illustrated above (Fig. 4-5B). Under the 
experimental condition, the accumulation of bacteriophage M13 is achieved with EK 
flow from left to right while bacteriophage M13 exhibits behavior consistent with nDEP.   
 
Figure 4-6. Fluorescence intensity profile on the longitudinal centerline across gate. The 
gate size is 3.3 µm. The FI decreases gradually with the extension of time with Vapp from 
1 s to 15 s. This phenomenon is consistent with the mechanism illustrated in Figure 4-5B. 
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This supports the accumulation of bacteriophage following the corresponding 
mechanism, which exhibits nDEP under experimental condition. 
 
4.3.2 Comparison of DEP Behavior of Bacteriophage M13 and Sindbis Virus 
Currently, bacteriophage M13 has to be labeled with a fluorescent moiety for 
monitoring and quantification. Given the well-studied structure of M13, it has a long and 
cylindrical protein shell enclosing the single stranded DNA, while both ends were 
constructed with minor coat proteins (Fig. 4-1). At pH = 7.4, bacteriophage M13 is 
negatively charged (pI=4.2) [17, 18]. The corresponding EP is towards the inlet reservoir, 
which is in an opposite direction with EO. In general, the outer layer of the protein shell 
is occupied by N-terminal region of p8 (Fig. 4-1B), which is negatively charged from an 
abundance of acidic amino acid residues. At pH = 7.4, primary amine groups on the N-
terminal is positively charged. During labeling, dye molecules with net-zero charge 
replace the exposed positively-charged primary amine groups. As a result, labeled 
bacteriophage M13 is more negatively charged. The corresponding EK velocity would 
decrease accordingly.  
The increase of the particle charge would result in the increase of the counter-ion 
concentration around the surface of the particle in addition to the movement of charge 
within the protein/DNA structure. The corresponding polarization of this counter-ion 
cloud would promote the polarizability of the particle.  
The conductivity of this medium is in the range of physiological solutions (e.g., 
≥8.8 mS/cm [19]). The behavior of bacteriophage M13 is consistent with nDEP under 
these experimental conditions, indicating the conductivity of the particle must be smaller 
than that of the medium (15.03 mS/cm).  
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In contrast, Sindbis virus exhibits behavior consistent with pDEP in the same 
channel. It seems unusual that these two viruses, being made up of largely similar 
materials, would demonstrate nDEP and pDEP rather some varying degrees of one or the 
other behaviors. Importantly, some details of the experiments can shed light on this 
curiosity. The Sindbis virus was captured in a medium conductivity of 2.12 mS/cm, and 
therefore this virus must have conductivity of a larger value. There are other known 
effects of changing the ionic strength (defining the conductivity) than the DEP forces. For 
instance, the EOF velocity will be smaller with the higher buffer concentration, which 
would also cause the change of total EK. It is difficult, if not impossible, to give a direct 
and quantitative comparison between the biophysical properties of these two viruses 
given the different experimental conditions. 
However, there are some speculative factors for comparing the behaviors for these 
two viruses. One important factor that affects the DEP behavior of the particle is the 
movement of the counter-ion cloud near their surfaces. These two virus particles are 
completely different shapes: SVHR is near-spherical with diameter of 68 nm [20] while 
bacteriophage M13 is filamentous with length of 880 nm and diameter of 6 nm [4, 5]. 
The distortion of counter-ion cloud around M13 would be smaller than that around 
SVHR under a consistent electric field. Another important factor could be the significant 
difference of their structural components. The SVHR has an additional insulating lipid 
bilayer envelope with glycoproteins (referred to as E1, E2 in Chapter 3) while 
bacteriophage M13 only has a protein shell.  It is reasonable to speculate that SVHR 
would exhibit a lower conductivity. However, those glycoproteins in the envelope 
connect the surface of the virus with the inner capsid shell [21], which could reasonably 
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contribute to a slightly elevated conductivity. The specific impact of these potential 
factors is indeterminate unless more profound research can be done.  
4.3.3 Future Application of the Method 
Currently, this device is still at its preliminary developing stage and operates in an 
analytical mode, simply capturing and concentrating the viral particles. Further 
improvements by integrating orthogonal side channels and valves onto the main channel 
will realize the control on the delivery of the concentrated sample. With valves, these side 
channels can be held electric silent during capture and be activated to transport the 
concentrated virus sample to further analysis either on-chip or off-chip. Instead of using 
conventional time-consuming methods, this rapid response technique would benefit 
clinical diagnostics in the future. 
 
4.4 Conclusions 
Fluorescently labeled bacteriophage M13 was captured and accumulated in this g-
iDEP device with V2S channel design. This new design demonstrates its ability to 
manipulate small particles, specifically submicron ones, by its application on Sindbis 
virus as well as the bacteriophage M13 shown here. These two viruses possess 
completely different shape, size, and structural components. From their different 
dielectrophoretic behaviors, the g-iDEP device shows its potential of manipulating 
different particles in submicron range. By carefully choosing the experimental condition, 
this g-iDEP device would be able to separate these small particles. These results bear 
important meaning for the future applications in virus detection and even the promising 
prospects of clinical analysis in fields such as point-of-care analysis. 
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CHAPTER 5 
BIOFLUID PRETREATMENT USING GRADIENT INSULATOR-BASED 
DIELECTRPHORESIS: SEPARATING CELLS FROM BIOMARKERS 
 
5.1 Introduction 
5.1.1 Traditional Techniques Associated with Diagnosis with Blood 
Blood is a remarkably rich and diverse medium that contains cells, platelets, 
proteins, exosomes, cellular debris and pathogens, which makes it the primary biofluid 
for clinical diagnostics [1-4]. Adult humans have roughly 2–3×1013 (20–30 trillion) red 
blood cells (RBCs) at any given time, comprising approximately 70% of the total number 
of cells in the human body [5]. Women have about 4 to 5 million erythrocytes per 
microliter of blood and men about 5 to 6 million. To achieve high reliability and 
specificity of diagnostics, fractionation of whole blood is required: separating protein-
enriched plasma from blood cells, including white and red blood cells [1, 2, 6, 7]. Based 
on the differences in physical properties (size, shape, density, magnetic property, and 
electrical property), many techniques have been developed for this separation, some of 
which are commonly used for clinical diagnostics. Compared with proteins, blood cells 
are much larger (D > 6 µm). Exploiting this fact are the two most common industrial and 
laboratory-based methods: centrifugation and filtration. These are simple methods, 
provide good performance, and can be executed at a large scale [8]. However, they are 
generally labor intensive, time consuming, and can damage analytes of interest. Aside 
from these mainstays, membranes are used, limiting the passage of cells with small pore 
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size. The performance drops dramatically after the membrane filter becomes saturated. 
Clogging is a major issue limiting the technique to dilute samples and a finite volume. 
5.1.2 Microfluidics Techniques with Blood 
Compared with these macro-scale techniques, microfluidic-based separation 
strategies are attracting more attention. These techniques enable the on-chip separation 
with many advantages over conventional methods, including small sample volume, short 
separation time, low cost, and compatibility with downstream analysis methods [9]. Some 
systems are designed to replace the benchtop capabilities in a smaller portable package 
(so-called micro total analysis systems, µTAs), promising to provide centralized 
laboratory results at any emergency location. Other systems have explicit goals 
associated with separating components for specific needs. For all these applications, the 
microfluidic-based system needs to conserve the diagnostic information contained in both 
cells and proteins for detection or further processing. 
Generally, the microfluidic techniques can be categorized as passive or active [7]. 
For passive separation methods, the principle is similar to that of macro-scale techniques. 
The particles are separated by their physical characteristics such as size, shape, and 
density with specific designs of micro-channels within the devices. Passive methods 
include deterministic lateral displacement [10, 11], microfiltration [12, 13], sedimentation 
[14], hydrodynamic separation [3, 4, 15, 16], and hydrophoretic filtration [17]. 
Deterministic lateral displacement was proven to be useful in separating particles in 
continuous flow [10] based on its hydrodynamic radius and was further utilized in 
separating cells in whole blood [11]. Theoretically, it has 100% recovery of plasma, 
though the technique suffers from various drawbacks such as the need for precise sheath 
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flow and high cost of fabrication. Thorslund et al. successfully applied commercial 
membrane materials into microfluidic devices for the filtration of blood sample, though 
the efficiency varies depending upon the chosen material and blood dilution ratio. Most 
membranes leaked blood cells even with a diluted blood sample [13]. 
Microsedimentation separated plasma from a few drops of whole blood in minutes [14]. 
However, this method diluted the plasma, making it difficult to analyze low concentration 
biomarkers. Hydrodynamic separation exploited viscous forces to separate plasma from 
blood, resulting in a separation process that is relatively time consuming due to the low 
Reynolds number of common samples [3, 15]. Improvements on the flow rate reduced 
the purity of the final isolated plasma [16]. Choi et al. [17] proposed a hydrophoretic 
filtration device as a sorting mechanism by separating platelets from diluted whole blood. 
However, only particles with diameter larger than half of the channel height can be 
ordered and focused, making it difficult to separate proteins (1-100 nm) from whole 
blood (particle size ranging up to a few micrometers). 
Active processes are characterized by external force field-based techniques, where 
acoustic [18, 19], magnetic [20] and electric forces [21] are utilized for separation. The 
acoustic method is simple, fast and dilution-free, but it damages the RBCs and causes 
aggregation [19]. Magnetic force-based techniques require labeling and during processing 
clogging is induced by mutual magnetic attraction, leading to inefficient cell sorting and 
false cell counting [20]. Nakashima et al. combined capillary and dielectrophoretic forces 
for the isolation of plasma. In their device, the cells were accumulated under nDEP forces 
while collecting plasma by capillary forces [22]. Yan et al. designed a microfluidic 
device with the combination of DEP and hydrophoresis for isolating of plasma from 
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blood with high throughput [7, 23]. In principle, active separation enables high-efficient 
and high-selective separation by tuning the force fields. However, both techniques 
require the application of AC frequency up to 1 MHz and a relative complicated 
fabrication process. 
The active approach explored here is based on an insulator-based gradient DEP 
(g-iDEP). It avoids large voltage and high frequency, while showing similar performance 
with a simple constant voltage applied at below 600V, as well as reducing the complexity 
of the fabrication process. The basic premise of the device lends itself to sample 
preparation of freely diffusible proteins in blood since relatively large bioparticles could 
be easily trapped without clogging while smaller proteins are thought to be transported 
through the system intactly. However, up to date, this obvious application has not been 
investigated. In this work, the idea of transporting proteins through the system while 
retaining the blood cells is experimentally tested. The basis of this work grows from 
related device designs that demonstrated concentration and isolation of blood cells [24], 
bacteria [25, 26] and viruses [27]. The transport of the purified fluid away from blood 
cells is a significant step towards applying the device as a real sample preparation tool for 
clinical use, which would establish the isolation and concentration of each bioparticle 
individually for further use while deliver a particle-free protein sample for immunoassay. 
Similar to the strategic approach demonstrated by other microfluidic blood manipulation 
works, this is both a demonstration of a new tool for integration in future systems and 
fulfills a niche for existing applications. The properties and layout of this system bear the 
potential to be integrated with high sensitivity rotor-based microimmunoassay after 
successfully realization of delivering a simplified protein solution [28]. 
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Convenient and important test probes for this system comes from current work in 
our laboratory focusing on freely diffusible protein cardiac biomarkers from blood [28-
30]. They serve as examples of proteins that are present in diagnostically important 
samples and as a general demonstration of the concept of sample preparation. For these 
biomarkers, early intervention leads to a much better prognosis in many cases of cardiac 
disease, such as myocardial infarction (MI). The rapid serial monitoring of target species 
is necessary for the accurate identification of a disease state, with which appropriate 
courses of treatment can be administered [31]. While a patient’s medical history, visible 
physical symptoms, and results of the electrocardiogram are all necessary factors to take 
into consideration, cardiac biomarkers are also valuable in achieving the diagnostic 
objectives. Optimal sensitivity of blood testing is expected to coincide with the time at 
which cardiac protein marker concentrations reach a maximum in the blood, which may 
occur several hours after the initial onset of symptoms [31]. Truly optimized diagnostic 
testing should satisfy several criteria: high sensitivity, low sample volumes, the ability for 
multiplex quantification, rapid analysis times, and operational simplicity while 
maintaining a low cost per analysis [32]. In order to achieve these, optimizations and 
alternations of current diagnosis need to be developed to extend the diagnosis of MI from 
centralized laboratories to the emergency room. 
In this study, fabricated and authentic samples are tested to show particle capture 
while transporting protein through the system. Proof of principle work was accomplished 
with polystyrene particles as surrogates of bioparticles and myoglobin as a model protein. 
These results were extended to human myoglobin (MyO) and human heart-type fatty acid 
binding protein (H-FABP) in the presence of red blood cells. These two model proteins 
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are two important biomarkers for monitoring cardiac disease. Consistent separation was 
observed showing retention of RBCs and passage of the two spiked protein biomarkers 
respectively, during individual trials. The numerical concentration of RBCs was reduced, 
with about 70 percent removed after one minute on average. Extended time resulted in 
relatively stable and low RBC count, which is highly introduced by the adherence of cells 
on the channel wall. Presenting these adhered cells can’t be further transported to 
downstream, the purified protein solution is made made available for potential follow-up 
detection or further processing. This study alters the use of the device from differentiating 
similar particles to providing a sample preparation step. 
5.1.3 Theory and Mechanism  
Dielectrophoresis is classically defined as the motion of uncharged suspended 
particles relative to the solvent media in an inhomogeneous electric field. It originates 
from the relative dielectric properties of the particle and the solvent [33]. The overall 
DEP force on a spherical particle is given in Eq. 2-12, proportional to the cube of particle 
radius (r) and CM factor ce# . In DC-DEP, the CM factor can be expressed as 
ce#  [34], which determines the direction (sign) of DEP force. However, its 
relatively narrow range, −# to 1, makes it less dominant for the absolute value of DEP 
force [35]. However, the radius of possible target particles can vary from 10 nm 
(ribosomes) to more than 100 µm (pollen). Even within a certain type of particle, size can 
vary by up to two orders of magnitude [36], which would make a considerable difference 
in the DEP force they experience in the same system. 
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When RBC and protein are in the DEP device with voltage applied, the 
superposition of EK and DEP affect their movements in the channel. DEP velocity is 
proportional to ∇𝑬# (Eq. 2-19), while EK velocity is proportional to E (Eq. 2-10). The 
observed movement of beads and RBCs is in the same direction with EO, which 
corresponds with estimations in published papers [37, 38]. Considering both beads and 
RBCs experience nDEP according to previous results [24, 36], the DEP points away from 
the narrowest portion between the teeth. When beads or RBCs move through the channel 
from inlet to outlet under a given voltage, both DEP and EK are increasing, as the 
distance between teeth becomes smaller. From previous COMSOL simulation [27], it is 
noted that ∇𝑬# increases more than E for a defined reduction in distance. So, when the 
DEP is large enough to counterbalance EK, the particles will be trapped and form a 
crescent on the convergent side of the gate. 
In blood, a typical human RBC has a disk diameter of about 6.2-8.2 µm [39] and a 
thickness with the thickest point of 2-2.5 µm and a minimum thickness point in the center 
of 0.8-1 µm, much smaller than most other human cells. Mature RBC develops in the 
bone marrow before releasing into circulation and therefore lacks a nucleus, which is 
important dielectrophoretically because polarization across a nuclear membrane will not 
occur. Intracellular charged proteins, hemoglobin, and cytosol molecules contribute to the 
highly conductive interior of RBCs (𝜎 = 0.53 − 0.31	𝑆/𝑚) [40, 41] and impact the 
ability of the cell to conduct charges through it [42]. The RBCs have a net negative 
charge based on linear electrophoretic, 𝜁 potential meausurements with a non-conductive 
( 𝜎 ≤ 1	𝜇𝑆/𝑚)  outer membrane [43, 44], which prevent electrical field lines from 
entering normal erythrocytes at low frequencies [45]. 
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Most proteins are in the size range of 1-100 nm.  The two proteins used here, 
MyO (18 kDa) and H-FABP (15 kDa) [46], are estimated to have a diameter of 3.46 and 
3.26 nm respectively [47]. The conductivity of the protein can be approximated using the 
value reported by Clark [48] for yellow fluorescent protein, which is 30.0 S/m at the 
maximum value and zero at the minimum. 
Including all above into consideration, the difference of DEP on RBCs and 
proteins in the same buffer system would mainly come from the r3 (Eq. 2-12). Because 
the size difference between the RBCs and proteins used here (MyO and H-FABP) are 
about 2-3 orders of magnitude, the DEP force on them should have a difference about 6-9 
orders of magnitude.  As a result, it is almost impossible to collect any protein under the 
voltage when the voltage is just high enough to capture RBCs in the DEP device (V2L, 
Fig. 5-1). All these show the viability of our proposal to purify protein from its mixture 
with RBCs. 
 
Figure 5-1. Schematic of the device used for separating RBCs from protein-spiked 
solution. By passing the sample through the channel under voltage, RBCs are retained in 
the channel while the purified proteins are passed to the outlet reservoir. The red and the 
light yellow color represent the sample with RBCs and purified protein sample without 
RBCs, respectively. The channel is designed to have a sawtooth channel with every three 
gates sharing the same gate size, gradually decreasing from 73 µm to 25 µm from inlet to 
outlet. 
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5.2 Materials and Methods 
5.2.1 Collection and Staining of Red Blood Cells 
Fresh whole blood was obtained by fingerstick from a human donor and was 
suspended in 1 mL isotonic phosphate buffer with 1.8 mg/mL EDTA. The sample was 
immediately centrifuged after resuspension followed with three washes to remove 
plasma. This RBC sample was then stained immediately using a previously described 
method [24]. The final pellet was resuspended in 115 mM sodium phosphate buffer at 
pH=7.4. Referring to the presumed mean corpuscular volume (MCV) of 90 fL [49], the 
cell count in the final RBC sample was estimated to be about 1x102 cells/nL. 
5.2.2 Labeling Protein with Fluorophore (Rhodamine) 
Purified human myoglobin (MyBioSource, San Diego, CA, USA), 7.33 mg/mL, 
and purified human heart-type fatty acid binding protein (Life Diagnostics, West Chester, 
PA, USA), 2.02 mg/mL, were used as received. NHS-Rhodamine (Thermo Fisher 
Scientific Inc., Waltham, MA, USA) was dissolved in DMSO (Invitrogen) to a 
concentration of 10 mg/mL. A volume of NHS-Rhodamine was added drop-wise to MyO 
and the sample was incubated in the dark at room temperature for 1 hour with shaking. 
Volume of NHS-Rhodamine was added to H-FABP and reacted in the same manner. The 
volume of NHS-Rhodamine was determined based on a 10-fold molar excess of dye 
during mixing with protein. Crude reaction mixtures were added to dialysis cups (Thermo 
Fisher Scientific) with a molecular weight cut-off of 3.5 kDa. Samples were dialyzed 
against 100 mM PBS, pH = 7.2 overnight. Proteins were diluted in the RBCs to ratios of 
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1:200 µL (MyO) and 3:200 µL (H-FABP) for analysis in the DEP device. The proteins 
and RBCs were mixed to a final concentration of 5 µg/mL and 1x102 cells/nL. 
5.2.3 Device Fabrication 
The microfluidic device was fabricated by an established procedure of 
photolithography, fabrication, and bonding techniques [50], as introduced in Chapter 3. 
The channel design used here is V2L (Fig. 5-1), same as used in previous work [26]. The 
gate size repeats every three with a decreasing trend from 73 µm near inlet to 25 µm near 
outlet. 
5.2.4 Experimental Procedure 
The experimental procedure was similar to those used for viruses (Chapter 3 and 
4). Initially, the internal channel was rinsed with running buffer, 115 mM sodium 
phosphate buffer at pH = 7.4, and treated with 4 mg/mL bovine serum albumin. After 
that, an aliquot of RBC-protein sample (10 µL) was introduced into the inlet reservoir, 
closest to the largest gate (Fig. 5-1). Running buffer was added in the outlet reservoir to 
eliminate the pressure driven flow. Electric potential (Vapp), ranging from 100 to 3000 V, 
was applied to the system with polystyrene particles and MyO. For biological system 
with RBCs and protein biomarkers, both MyO and H-FABP, lower potential (100 to 500 
V) were applied. Depending on each individual experimental and sample, the time with 
voltage on varies from a few seconds up to a few minutes.  
5.2.5 Separation and Data Collection 
The behavior of polystyrene particles, RBCs and proteins in the DEP device was 
monitored using an Olympus IX70 inverted microscope in epi-fluorescence configuration 
illuminated by a mercury lamp. Light was detected with a QICAM CCD camera (Q 
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Imaging, Surrey, British Columbia, Canada). Videos and still images were recorded using 
a commercial program (Stream Pix III program, NorPix, Montreal, Quebec, Canada). 
Further image processing was performed using Image J (NIH, Bethesda, MD).  
5.2.6 Safety Consideration 
All biological samples used here are Biosafety I or II level. All above procedures 
are performed in a laboratory with an approved BSL II environment. 
 
5.3 Results and Discussion 
5.3.1 Purification in Model System 
A colloid of labeled protein and model particles were used to represent blood and 
test the system. Larger cells and other bioparticles were represented by polystyrene 
particles (200 nm) and fluorescently labeled MyO was chosen to represent proteins. For 
preliminary experiments, the particles and MyO were placed in the device separately 
before voltage was applied. For each experiment, images were captured in a specified 
area of the sawtooth channel (dashed box, top Fig. 5-2). For the labeled MyO sample, FI 
remained even and constant within the channel area with Vapp from 500 V to 2000 V 
(bottom left Fig. 5-2). In contrast, for polystyrene colloid, there were obvious effects. At 
lower voltages, 500 V and 1000 V, streaming (red arrows, bottom right Fig. 5-2) was 
observed, and trapping and accumulation were noted at higher Vapp (2000 V, red squares, 
bottom right Fig. 5-2). 
Mixed samples of the particle colloid and protein solution were placed in the 
device (Fig. 5-3). The channel was initially filled with particle colloid, allowing even 
distribution throughout the channel. The protein solution was then introduced through 
	 97 
inlet and the labeled myoglobin was transported through channel under Vapp by 
electrokinetic effects.  Flux of the proteins increased with higher Vapp, consistent with the 
increase of even background fluorescence. While an overall increase was observed, no 
evidence of localized protein concentration at higher Vapp was observed. 
 
Figure 5-2. Manipulation of MyO solution and polystyrene particle colloid separately in a 
microchannel with applied voltages at 500 V, 1000 V, and 2000 V.  Left: myoglobin 
solution, no significant FI increase is observed anywhere within the channel up to 2000 V 
(even up to 3000 V, data not shown here). Right: polystyrene colloid, particles begin to 
stream (transported vertically in image, red arrows) at 500 V and 1000 V. Trapping, as 
indicated by an obvious FI increase, occurs at 2000 V (red boxes). 
 
Similar to the individual solution/colloid experiments, no areas of high 
background FI were noted (which would indicate local increase of protein concentration) 
and the particles were seen to stream at 500 V and minimum trapping started to appear at 
	 98 
1000 V, with bright accumulation at the same spots at 2000 V. However, there was a 
slight change of behavior for polystyrene particles with protein present. When there were 
only polystyrene particles, the streaming region was half way into the diamond shaped 
area between each gate even at 1000 V. With protein present, particles were mainly 
focused on the centerline throughout the channel even at a lower Vapp, 500 V. The altered 
behavior of the particles is likely due to surface adsorption of the protein changing the 
zeta potential and hence the electrokinetic properties of the particles. 
 
Figure 5-3. Manipulation of mixture of MyO and 200 nm polystyrene particles in a 
channel. The channel was initially filled with polystyrene particles with no clear capture 
and then fluorescently labeled MyO was added. The increasing background FI is caused 
by introduction of myoglobin during the cumulative time period with voltage on. With 
increased Vapp and longer voltage application time, more MyO is observed to be 
transported to the end of the channel, which consequently causes the increase of the FI.  
 
5.3.2 Trapping of RBCs from Mixture with Protein Solution 
Two model protein solutions, either MyO or H-FABP, were mixed with RBCs 
isolated from whole blood and tested in the device. The RBCs were consistently trapped 
while the protein solution passed through the device (Fig. 5-4). Homogeneous 
fluorescence background, indicating freely diffusing protein filled the contours of the 
sawtooth channel. Most RBCs were focused near the left side of the gate, consistent with 
trapping by nDEP.  
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Figure 5-4. Illustration of RBC capture in the protein solution with 400 V applied on the 
whole channel. Both frames showed the last set of gates in the channel, from Gate 25 to 
Gate 27. In the left frame, the protein solution is MyO while the protein solution is H-
FABP in the right frame. It is clear that in both situations, RBC got captured at all those 3 
gates (bright dots shown in the red rectangular) while there was no significant FI change 
in the background. 
 
The last set of gates in the channel was chosen as a representative zone to 
examine capture. FI was monitored in a region of interest (ROI) before gate (left side of 
gate), as well as a similar ROI after the gate (right side of gate). At lower voltages 
insufficient for capture (e.g. 100 V, Fig. 5-5), the fluorescence signal after the gate was 
qualitatively similar with an offset of about one second, which was consistent with the 
RBCs passing the gate without being retained.  
At higher voltage (e.g. 400 V, Fig. 5-6), FI in the left ROI increases after the 
voltage was applied at 5 s. After 15 s, the intensity was relatively stable until the voltage 
is removed at about 35 s. In contrast, FI after the gate (right ROI) remained low and 
stable. These data are consistent with RBCs being trapped and retained by DEP force, 
whereas the proteins flow easily through the system.  
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Figure 5-5. RBC behavior in ROI before and after gate at lower voltage, 100 V. Whole 
channel was filled with the RBC and MyO mixture at the very beginning. The FI shows 
both RBCs and MyO passing through gates at 100 V (signals offset for clarity). 
 
 
Figure 5-6. RBC behavior in ROI before and after gate at higher voltage, 400 V. Whole 
channel was filled with the RBC and MyO mixture at the very beginning. The FI shows 
RBCs being captured at ROI before gate.  
 
Multiple trials have shown consistent phenomenon of the capture of RBCs at this 
applied voltage (400 V, Fig. 5-7). FI at ROI before and after gate has been compared 
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using data sets from multiple gates with the same size in repeated individual experiments. 
Capture of RBCs was demonstrated consistently, either with MyO or H-FABP, at 400 V 
at both gate size 26.2 µm and 25.3 µm, which are the last two sets of gates. Control 
experiments were performed with no voltage, showing little fluorescence signal change 
for both ROIs before and after gate. The slight decrease of FI observed in the ROI after 
gate (Fig. 5-6 and 5-7) can be introduced by the depletion of RBCs, leading to the 
decrease of the average fluorescence signal. 
 
Figure 5-7. RBC behavior in ROI before and after gate at various voltage in multiple 
individual trials(n≥5). Whole channel was filled with the RBC and protein mixture at the 
very beginning. Vapp (varying from 0 V to 500 V) was applied when mixture was evenly 
distributed. The last two sets of gates (gate size 26.2 µm and 25.3 µm respectively) were 
chosen as representatives for the data analysis. The left half of the bar data shows the data 
at gate size 26.2 µm. The blue bars show clear FI increase at ROI before gate for both 
MyO (lighter blue) and H-FABP (darker blue), indicating consistent capture of RBCs. 
The brown bars show clear FI decrease at ROI after gate for both MyO (lighter brown) 
and H-FABP (darker brown), indicating consistent depletion of RBCs at ROI after gate. 
Similar behavior is observed at gate size 25.3 µm, represented by the right half of the bar 
figure. 
 
5.3.3 RBC Exclusion for Purified Protein Sample 
After verifying the trapping of RBCs near the gates in the sawtooth area, the 
efficiency protein purification was investigated. The last gate (Gate 27, G27) was 
examined in detail. Before voltage was applied, both protein and RBCs were evenly 
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distributed in the channel as evidenced by the homogeneous background and even 
distribution of bright spots. Images in straight channels before and after the sawtooth-
zone were captured (Fig. 5-8, upper image) and compared. Once voltage was applied 
images consistent with RBCs being captured was observed. A zone without bright spots 
formed after G27, consistent with no RBCs being present. This is interpreted as the RBCs 
upstream of the gate were being trapped while those initially distributed after G27 moved 
with the bulk flow. Counting RBCs in a representative region (red box, Fig. 5-8) in the 
purified zone indicated a dramatic decrease of RBC count by about 70 percent in one 
minute with applied voltage. There were a few RBCs remaining in the region even after 
an extended time with voltage. These RBCs were observed to remain still throughout the 
whole experimental procedure, which were mostly due to the adhering on the surface of 
the channel wall. Based on the theoretical basis and the FI before and after the gate, the 
protein biomarkers are considered to flow through the channel unchanged, which gives 
full recovery within the error of the fluorescence measurement. 
5.3.4 Context of Capabilities  
The capabilities of various classic and microfluidic approaches vary according to 
the specific application. Some devices are aimed at full sample preparation and analysis 
at the point of care, while others aim to provide a specific role in larger manipulation 
strategies. This work specifically demonstrates that the forces and format of the 
insulated-based dielectrophoresis system can provide cell-free solution for further 
processing on a timescale and volume sufficient for modern high sensitivity 
immunoassay. This demonstration also provides a new tool for use in other systems 
where the time, volume, layout, flow, and electric field constraints align with this 
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process. A full summation and quantitative comparison, where possible, of related 
microfluidic blood preparation techniques is listed (See Supplemental Table 5-S1). 
 
 
Figure 5-8. RBC exclusion from its mixture with MyO. The whole channel was filled 
with the RBC and MyO mixture at the very beginning. The mixture was inspected to 
make sure it was evenly distributed in the channel before Vapp (400 V) was applied. Once 
the voltage was turned on, the RBCs in the sawtooth-zone of the channel were all 
captured at the gates with RBCs located after the last gate (G27) flowing towards the 
outlet, which created a purified zone of protein solution right after the G27. By counting 
the RBCs in the red box (an example of the purified protein region), it is clear to see that 
most of RBCs in this region was excluded by about 70 percent on average, within one 
minute with Vapp on. With further extension of time period, the RBC count in this region 
is relatively stable at a low number with slightly decrease due to the adherence of cells on 
channel wall. Error bars are representing the standard deviation (n=3). 
 
 
5.4 Conclusions 
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With the sawtooth insulator-based dielectrophoretic device, separation of cells 
and two of the protein biomarkers for myocardial infarction is demonstrated. Within one 
minute, the count of RBCs has been minimized, while creating a purified protein 
biomarker zone for follow-up detection. This step forward is significant for its 
application in biosample pretreatment. The short time and high efficiency will enable 
immediate assessment of biomarkers in human blood for disease, especially when there is 
an acute need for situations like symptoms of a heart attack. There is little or no direct 
comparison with classic techniques in term of volume, time, fine-scale sample 
manipulation and simplicity, as the case with many microfluidic techniques. Other 
microfluidic techniques are designed for specific goals and often have integrated designs 
aiming at a large variety of metrics which do not lend themselves to direct comparison. 
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CHAPTER 6 
SUMMARY AND CONLCUSIONS 
 
6.1 Analysis using Dielectrophoresis 
The capabilities of dielectrophoresis (DEP) to manipulate bioparticles have been 
expanded with new applications demonstrated in past decades. Biophysical properties of 
various bioparticles have been measured and exploited for separation and concentration 
within a microchannel paradigm. Dielectrophoretic methods of handling and analyzing 
samples can be modified through various approaches, such as applying different types of 
electric field (e.g. AC or DC) and changing the dimensions of the microchannel. These 
easily-tuned properties and the corresponding convenient fabrication lead to the 
realization of utilizing dielectrophoresis in analyzing different biological samples, 
especially in the field of separation science.  
The gradient insulator-based dielectrophoretic (g-iDEP) device has proven its 
ability to manipulate different bioparticles. In this dissertation, the successful 
manipulation of bioparticles in submicron range is achieved with an evolved g-iDEP 
device (V2S). Previous work demonstrates the viability of the V1 microchannel for 
capturing larger bioparticles, though most capture and concentration occurs at last two 
sets of gates while all larger gates showed little evidence of capture. This improved V2S 
design increases the resolving ability of the device and extends the application range to 
submicron particles by creating a higher characteristic ec value increasing linearly 
throughout the channel. Using this new V2S microchannel, it is demonstrated for the first 
time that Sindbis virus (SVHR) is successfully labeled, characterized and manipulated 
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with DEP (Chapter 3). This icosahedral-shaped arbovirus responds to applied voltage as 
low as 70 V in a few seconds and demonstrates consistent capture and increased 
concentration with increased Vapp in the device. Further analysis indicates that SVHR 
exhibits pDEP under the experimental condition.  
These results bear important implications meanings for the future of virus 
detection and the promising prospect of clinical analysis in field such as point-of-care 
application. Instead of using conventional time-consuming methods, this rapid-response 
technique would benefit clinical diagnostics or detection in the future. Further 
optimization and integration with down-stream analysis would enable identification, 
isolation, and quantification of viruses in a single device that allows for small sample 
size, rapid detection, high sensitivity, and short processing time. This could be further 
developed for research in vaccine development, clinical treatment, and therapies [1-4].   
Another virus with a representative filamentous shape, bacteriophage M13, 
reconfirms the feasibility of utilizing the new V2S microchannel for manipulating 
bioparticles in submicron range (Chapter 4). Similar capture and accumulation as with 
SVHR were observed, while the dielectrophoretic phenomenon indicates bacteriophage 
M13 exhibits nDEP under the experimental condition. This successful concentration of 
bacteriophage M13 provides a novel, fast, and convenient method to generate high-
quality samples for application in phage therapy [5], phage display [6, 7], and other 
nanotechnologies [8-10]. 
Besides the impact on the related applications, the manipulation of the SVHR and 
bacteriophage M13 also reveals their different dielectrophoretic behaviors. Given the 
different experimental condition, it is difficult to give a direct and quantitative 
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comparison between their biophysical properties. However, it is reasonable to speculate 
the distinguishing ability of this g-iDEP device on various submicron particles can be 
established by carefully tuning the experimental condition. The voltage-dependent 
capturing behavior was studied and a threshold voltage value was estimated. The 
corresponding characteristic ec value was estimated to be 4.48 × 1010 V/m2 for SVHR and 
9.60 × 1010 V/m2 for bacteriophage M13 using COMSOL models. These results indicate 
a potential for clinical and diagnostic applications, where bioparticles such as cells, 
viruses, and proteins play crucial roles. Since the dielectrophoretic properties vary with 
the composition, shape, size and charge of the target analyte, it is expected that different 
kinds of bioparticles would have unique dielectrophoretic behavior resulting from the 
structural variations. 
By combining the work presented on submicron bioparticles with previous 
research on larger bioparticles, this g-iDEP device can be used for separating more 
complex biological sample (e.g. biofluid) by isolating different particles (across the size 
range) with careful choices on the size of gate. 
This idea is primarily tested by utilizing this g-iDEP device (V2L) as a 
pretreatment tool for biofluid sample. For example, in a blood test, fractionation of whole 
blood is required to achieve high reliability and specificity of diagnostics, i.e., separating 
protein enriched plasma from blood cells, including white and red blood cells. Currently, 
with the device still at its preliminary developing stage and operation in an analytical 
mode, a simplified system with red blood cells (RBCs) and cardiac protein biomarkers 
(myoglobin, MyO, and heart-type fatty acid binding protein, H-FABP) are studied 
(Chapter 5). In this research, fabricated and authentic samples are tested to show particle 
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capture while transporting free diffusible biomarkers through the system. Proof of 
principle work is accomplished with polystyrene particles as surrogates of bioparticles 
and myoglobin as a model protein. These results are extended to MyO and H-FABP in 
the presence of RBCs. Within one minute, RBC count is minimized while creating a 
purified biomarker zone for further processing.  
The transport of the purified fluid away from blood cells establishes the potential 
of isolating all free diffusible biomarkers. This potential is a significant step towards 
applying the device as a real sample preparation tool for clinical use, which would isolate 
and concentrate each bioparticles individually for further use while delivering a 
simplified protein sample for immunoassay. In this way, the diagnostic information 
contained in both cells and proteins are conserved for detection or further processing. 
This work can help the development of current diagnostics from centralized laboratories 
to the emergency room. Short time and high efficiency enables the immediate assessment 
of biomarkers in human blood for disease, especially when there is an acute need for 
situations like symptoms of a heart attack. 
 
6.2 Future Directions 
Truly optimized diagnostic testing should satisfy several criteria: high sensitivity, 
low sample volumes, the ability for multiplex quantification, rapid analysis times, and 
operational simplicity, while maintaining a low cost per analysis [11]. The ultimate goal 
of this device is to achieve these criteria and extend the clinical diagnosis from 
centralized laboratories to the emergency room. 
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Generally, the diagnosis and confirmation of a disease is a time-consuming, labor-
intensive, and expensive process. The initial diagnosis is made by observation of certain 
symptoms of the patient. If there is an infection, identifying the pathogen can require a 
lengthy process, particularly if it is a rare pathogen. Besides routine blood or urine tests, 
identification of the pathogen will rely on microculture, molecular recognition, nucleic 
acid-based assays, and so on. At least one of these methods is necessary to verify the 
pathogen. However, a false result may still be produced even with the combination of all 
these methods.  
The g-iDEP device proves its successful isolation and separation with a few 
bioparticles, from larger ones such as RBCs and bacteria to submicron range viruses. 
Preliminary investigation as a sample pretreatment step has shown its potential of 
delivering purified free diffusible biomarkers while isolating and concentrating each 
bioparticle individually. The conserved diagnostic information in both bioparticles and 
biomarkers can be used for follow-up analysis. This is both a demonstration of a new tool 
for integration in future systems and fulfills a niche for existing applications. 
Further improvement by integrating orthogonal side channels and valves onto the 
main channel will realize the control on the delivery of the concentrated bioparticles. 
With valves, these side channels can be held electric silent during capture and be 
activated to transport the concentrated virus sample to further analysis either on-chip or 
off-chip. Furthermore, the properties and layout of this system integrate with 
electrophoretic exclusion for protein separation (unpublished work in Dr. Hayes group) 
and high sensitivity rotor-based microimmoassay [12]. A prospective device arrangement 
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is given, including isolation of bioparticles, further separation of proteins, and 
immunoassay (Fig. 6-1). 
 
Figure 6-1. Prospective device arrangement for separation, purification, and detection. 
 
To achieve the full integration of parts of the prospective device, a significant 
amount of research is necessary, as well as the development of current fabrication 
techniques. Considering the current limitation of monitoring particle movement using 
fluorescence microscope, explorations of new monitoring techniques and methodologies 
are required to realize the label-free analysis of bioparticles. This would dramatically 
simplify the complexity of the sample preparation and achieve the manipulation of intact 
biological samples. With the improvement and development of g-iDEP, it will show an 
increasing impact on a broad range of fields, including vaccine development, clinical 
treatment, diagnostic methods and other nanotechnologies. 
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Appendix A 1: Simplified Temporal Model for Sindbis Virus Transportation 
 
In Chapter 3, the experimental results indicate the transportation of viral particles 
toward the outlet reservoir and corresponding accumulation at the right side of the gate 
upon application of Vapp. This phenomenon indicates that virus particles move in a 
manner consistent with pDEP. Assuming the only forces present are described by CM 
factor, the conductivity of the Sindbis virus is larger than the conductivity of the 
surrounding medium.  
From the plot of integrated FI versus applied voltage (Fig. 3-4), there is a 
correction between the amount of virus being captured and the applied voltage. One of 
the potential reasons for this could be mass transportation, which is mainly driven by EK. 
In order to demonstrate this, a simplified model has been created to simulate the mass 
transportation of the particles on the centerline through gate, using G20 as an example 
(Fig. 3-S1).  
 
 
Figure 3-S1. G20 was chosen as the representative gate for the mass transportation of the 
viral particles. The centerline is chosen for the simplified model because it is symmetric 
along the vertical line connecting the tips of the teeth for G20, which is point xn. xi is 
representing any point on the centerline.  
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When considering all particles on the centerline, they will all move along the 
direction of centerline from inlet to outlet. Corresponding electric field E on the indicated 
region has been calculated using COMSOL multiphysics software (Fig. 3-S2). Since 
particles are observed to move in one direction (unless captured), only viral particles on 
the left side of G20 are considered for further simulation, from x=0 to x=554 (xn).  
A  
B  
Figure 3-S2. Distribution of Electric filed along the centerline of G20. (A) Electric field 
throughout the centerline of G20 when Vapp = 400 V. (B) Electric field on the left side of 
the centerline of G20 with Vapp varying from 100 V to 600 V. 
 
For particles on the left, the time (ti) needed for any virion at position xi to reach 
xn under only EK can be expressed as: 
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 𝑡h = G MA() = G ∆A = G c3(AeA)c/h  (3-S1) 
where Ei is the local electric field at point xi, which is always along the centerline towards 
outlet. With this equation, the time needed for viral particles at each location (xi) to be 
transported to G20 (xn) can be calculated and plotted (Fig. 3-S3). 
 
 
Figure 3-S3. Transportation time for virions at location xi to reach G20 (xn) with Vapp 
varying from 100 V to 600 V.  
 
Within the time period of transporting virions at location xi to G20 (xn), all virions 
locate between xi and xn will reach G20 (xn). Assuming all virions are evenly distributed 
in the solution, as well as on the centerline, the number of viral particles at each location 
(xi) would be the same. As a result, the percentage of viral particles that can reach xn 
during this time period (ti) can be calculated using following equation (Eq. 3-S2). The 
corresponding relationship between the proportion of virions on the centerline that can 
reach xn in a certain amount of time (ti) can be plotted. 
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 𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛	𝑜𝑓	𝑣𝑖𝑟𝑖𝑜𝑛𝑠	𝑟𝑒𝑎𝑐ℎ	𝑥5	𝑎𝑡	𝑇𝑖𝑚𝑒	𝑡h = cc- (3-S2) 
 
 
Figure 3-S4. Proportion of all virions on the centerline that can reach G20 (xn) within a 
certain amount of time (ti = 0.1) with Vapp varying from 100 V to 600 V. 
 
By choosing a certain time point (ti = 0.1), the proportion of virions that can be 
transported to xn at Vapp varying from 100 V to 600 V can be calculated and plotted (Fig. 
3-S4). By comparing the simulated virions transportation with experimental data (Fig. 3-
4A), the result can qualitatively match the theoretical capture mechanism. At lower 
voltages, even though viral particles are being delivered to the capturing zone under EK, 
the counterbalancing DEP is not high enough to stop or capture them. However, with 
higher voltages applied, the virus accumulating trend (Fig. 3-4A) qualitatively matches 
the increasing trend of virus transportation (Fig. 3-S4). This further verifies that DEP is 
high enough to capture most, if not all, viral particles that can be delivered to the 
capturing zone.  
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Appendix B 1: Context of Capabilities for Microfluidic Blood Sample Preparation 
Table 5-S1 Summation and Quantitative Comparison of Related Microfluidic Blood Preparation Techniques 
 
* The 3 min is estimated based on the flow rate for the solution from inlet to outlet. Amount of sample 
processes are not clear from original work.  
** Both whole blood and diluted blood were used in the research. 
*** Diluted blood was used 
****  There are two parts: FD and PD. PD is more for the plasma separation without presenting any detailed 
volume. In FD part, it is said there are 1 mL of blood was running for about 1 hour. 
***** Based on the mechanism, the design may not be used for separating plasma from whole blood. 
 
 
 
 
 
Category (cite number) Lead author Year 
Initial 
Volume 
Total 
time 
Dilution during 
the process Final volume 
Hemolysis 
noted Flow rate 
Integrated 
design 
Sedimentation (14) Tachi 2009 3 µL 3 min* Y (x6) N/A <0.2% ~1.0  µL /min N 
Microfiltration 
(12) Crowley 2005 ** 5 µL N/A N/A N/A Y ~1.0 µL /min 
N 
 
(13) Thorslund 
2006*** 
(membrane based) 
Up to 300 µL N/A N/A 100 µL (from 300 µL) 
depends Not relevant N 
Deterministic 
lateral 
displacement 
(10) Huang 2004 
& 
(11) Davis 2006**** 
Unclear Not denoted. N 
N/A N/A 1000 µm/s & 1 µL/min 
N 
Hydrodynamic 
separation 
(15) Yang 2006 N/A N/A N 15%-25% N/A 10 µL/h N 
Fan 2008 N/A <10 min N/A N/A N/A Not relevant Y 
Browne 2011 0.5-1.5 µL <1min N N/A N/A ~0.1 µL /min Y 
Hydrophoretic 
filtration (17) Choi 2011
***** N/A N/A N/A N/A N/A 1-20 µL /min N 
Acoustic 
(18) Shi 2009 
& 
(19) Doria 2011 
16 µL ~3 m N 3.8 µL N/A 
10.6 nL/s 
plasma 
extraction 
Y 
DEP 
(22) Nakashima 
2010 5 µL N/A N 300 nL N/A Indeterminate 
N 
(7) Yan 2014 N/A N/A N N/A N/A 10 µL/min N 
g-iDEP Ding et al. 10 µL N/A 20:1 + pL N 100 nL/s N 
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